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Abstract
Understanding the interaction of proteins with charged molecules is of great importance in a
wide field of health-related research topics. [1, 2] Nanoparticles coated with polyelectrolytes,
interact with proteins once immersed in the human blood stream. A so called protein
corona is formed and will modify the physical and chemical properties of nanoparticles,
determining its path through the organism. [3] In the case of small, charged molecules, the
uptake of toxins by proteins have a major influence on the efficiency of drugs on the one
hand, and can hinder the proteins in their function, on the other hand. [4]
The first part of the thesis explores the charge-charge interaction between proteins and
polyelectrolytes. Polyacrylic acid (PAA) is used as a short model polyelectrolyte with
25 negatively charged repeating monomers, thus aggregation effects are avoided. Its interac-
tion with human serum albumin (HSA) is investigated in a comprehensive experimental
and theoretical study. HSA is the most abundant protein in blood serum and is negatively
charged at physiological pH. Computer simulation studies were performed by Xiao Xu
within the framework of his PhD thesis. Thermodynamic data were collected by means of
isothermal titration calorimetry (ITC) and structural analysis performed using small-angle
neutron scattering (SANS). The interaction was analyzed by determining binding con-
stants and related thermodynamic information through ITC as a function of ionic strength
(20 − 100 mM) and temperature (25 ◦C − 37 ◦C). One to one binding is found and a
positive patch on the protein was identified as binding site. Theoretical and experimen-
tally determined free energies of binding ∆Gb are in excellent agreement. The entropic
contribution due to the release of counterions upon binding is identified as main driving
force for binding, whereby three ions are found to be released upon adsorption. Structural
investigations give proof of the stability of the protein beside adsorption.
In the second part, the interaction of two uremic toxins, namely phenylacetic acid (PhAA)
and indoxyl sulfate (IDS), with HSA is studied in aqueous solution. These molecules are
known to accumulate in patients with declining renal function suffering from chronic kidney
disease (CKD). [5] Again, thermodynamic analysis of data obtained by systematic ITC
experiments reveal two binding sites for both of the two toxins, with different binding
affinities and stoichiometry. The dependence of binding affinities on ionic strength is small
in contrast to PAA adsorption to HSA. Thus, a key conclusion here is the identification
of the favorable hydrophobic interaction as the driving contribution for adsorption and
the enthalpy-entropy compensation (EEC) effect comes into play. SANS studies of high
concentrated HSA-toxin solutions proofed the stability of the protein structure and shed
light on the interparticle interaction of HSA-toxin complexes. Additionally, the effect of
urea induced modification of HSA, as a known pathophysiological condition of CKD, on the
binding of the two toxins was studied. Both thermodynamic and structural investigation
evidenced only minor effects of the absorption behavior of the protein.
In general, HSA is structurally robust regardless of ligand uptake as revealed by SANS.
This finding allows the interpretation of ITC data by confirming that the measured heat
signals are purely associated to the binding process. The present thesis has demonstrated
that a full thermodynamic analysis in combination with theoretical modelling can provide
a comprehensive understanding of binding in terms of identifying driving forces and their
contributions to protein ligand interaction.
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Zusammenfassung
Die Wechselwirkung zwischen Proteinen und geladenen Molekülen spielt eine wichtige Rolle
in vielen gesundheitsrelevanten Bereichen. [1, 2] Nanopartikel, die mit Polyelektrolyten
überzogen sind, wechselwirken mit Proteinen sobald sie mit Blut in Kontakt kommen. Ein
sogenannter Proteinkranz bildet sich und beeinflusst die physikalischen und chemischen
Eigenschaften des Partikels, damit auch seinen Weg durch den Organismus. [3] Im Falle
kleiner, geladener Moleküle, wie z.B. Toxinen, kann ihre Aufnahme durch Proteine einerseits
die Effizienz vonWirkstoffen und andererseits die Funktionalität des Proteins beeinflussen. [4]
Der erste Teil dieser Arbeit untersucht die Ladungswechselwirkung zwischen Proteinen und
Polyelektrolyten. Dabei wird Polyakrylsäure (PAA) als kurzes Modell-Polyelektrolyt mit 25
negativ geladenen Wiederholeinheiten verwendet, sodass Aggregationen vermieden werden.
Ihre Wechselwirkung mit Humanalbumin (HSA) wird in einer umfassenden experimentellen
und theoretischen Studie untersucht. HSA ist das häufigste Protein im menschlichen Blut
und ist bei physiologischem pH negativ geladen. Die Computersimulationen in dieser Arbeit
wurden von Xiao Xu im Rahmen seiner Promotion durchgeführt. Thermodynamische Daten
wurden mit Hilfe von Isothermer Titrationskalorimetrie (ITC) gesammelt und strukturelle
Untersuchungen mit Hilfe von Neutronenkleinwinkelstreuung (SANS) durchgeführt. Durch
die Analyse von Bindungsaffinitäten und weiteren thermodynamischen Daten bei verschiede-
nen Ionenstärken und Temperaturen, konnte die Wechselwirkung bestimmt werden. Das
Ergebnis zeigte eine eins zu eins Bindung und die Bindungsstelle des Proteins konnte
identifiziert werden. Die theoretisch und experimentell bestimmten Bindungsenergien ∆Gb
stimmen sehr gut überein. Der entropische Beitrag, der durch die Freisetzung von Gegenio-
nen im Bindungsprozess entsteht, konnte als treibende Kraft für die Bindung identifiziert
werden, wobei drei Gegenionen freigesetzt wurden. Die strukturellen Untersuchungen weisen
eine stabile Proteilstruktur unabhängig von der Adsorption durch PAA auf.
Im zweiten Teil der Arbeit wird die Wechselwirkung zweier uremischer Toxinen, nämlich
Phenylessigsäure (PhAA) und Indoxylsulfat (IDS), mit HSA in wässriger Lösung untersucht.
Diese akkumulieren im Körper von Patienten, die an chronischem Nierenversagen (CKD)
leiden. [5] Auch hier wurden systematische ITC Experimente durchgeführt und die Analyse
der erhobenen Daten weiste die Existenz von zwei unterschiedlichen Bindungsstellen mit
unterschiedlicher Stöchiometrie für beide Toxine auf. Im Gegensatz zu PAA, hängen die
Bindungsaffinitäten hierbei nur in geringem Ausmaße von der Ionenstärke des Systems ab.
Eine wichtige Schlussfolgerung ist daher, dass begünstigende, hydrophobe Wechselwirkun-
gen die treibende Kraft für die Adsorption von Toxinen an HSA sind, und dass hierbei
die Enthalpie-Entropie-Kompensation (EEC) zu tragen kommt. Weiterhin zeigen SANS
Untersuchungen an hochkonzentrierten HSA-Toxin Lösungen, dass die Proteinstruktur trotz
Adsorption stabil bleibt und konnte außerdem über Interpartikulare Wechselwirkung von
HSA-Toxin Komplexen aufklären.
Im Allgemeinen ist HSA strukturell unverändert durch die Adsorption von Liganden. Diese
Feststellung erlaubt die Interpretation von ITC Daten, da damit gemessene Wärmeprozesse
ausschließlich von Bindungsprozessen herrühren und nicht durch z.B. Entfaltungsprozesse
beeinflusst sind. Die vorliegende Arbeit konnte zeigen, dass eine ausführliche thermody-
namische Analyse durch Kombination von theoretischer mit experimenteller Arbeit, eine
umfassende Einsicht in die Mechanismen von Bindungsprozessen ermöglicht.
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1 Introduction
The interaction between proteins and ligands is involved in many essential tasks vital to
the survival of all organism and has gained even more significance with growing interest in
biomaterials and medical devices. [3] Ligands can be small molecules, such as metabolites
and pharmaceuticals, or larger molecules such as polyelectrolytes (PE) that form complexes
with biological macromolecules such as proteins. [6] On the one hand, many processes in
the human organism involve protein interaction to small, charged molecules, such as active
agents, toxins and fatty acids and are therefore of obvious clinical importance. On the other
hand, development of polymeric devices for potential biotechnological application has grown
significantly in recent years. [7] Polyelectrolytes can be used to synthesize nanoparticles
which have been invented as early as in the 1990’s to enable a more efficient delivery of
pharmaceuticals to their target site. [8, 9] However, once introduced into the blood stream,
these particles face the problem of adsorption of proteins to the charged polymeric surface
and immediately forming a so called protein corona. [10–12] These adsorbed proteins may
trigger an immune response of the body [13, 14]. Hence, nanotoxicology [15] that deals with
these unwanted side effects of nanoparticles must consider the interaction of proteins with
polyelectrolytes.
In all the scenarios described above, interaction is governed by a complex interplay of
different driving forces. A deeper understanding of these driving forces is crucial, but
at the same time still represents a challenging task to accomplish. As a result, a lot of
resources are put into the elucidation of different contributions in the process of protein
adsorption. [16, 17] However, the shear number of different systems and conditions under
which interaction takes place, has led to numerous protein and particle specific studies
and thus it is impossible to come to general conclusions. Here, the choice of simple model
systems studied by combining experimental and computational methods, can give insight
into driving mechanisms.
An interesting model protein to study, when it comes to protein ligand/polyelectrolyte
interactions, is human serum albumin (HSA), as it is the most abundant protein in blood.
HSA is an important transport protein that interacts with substrates as e.g. fatty acids [18,
19] and pharmaceuticals in a specific manner. [20] Also, HSA is clinically relevant as it plays
an important role in renal clearance, where uremic toxins accumulate in large numbers
in the blood of patients suffering from chronic kidney disease (CKD). [21] They interact
detrimentally with plasma proteins and lead to a high risk of cardio-vascular diseases. [5,
22, 23] High concentrations of toxins are reported in patients with end-stage CKD and thus
their interaction with HSA needs to be understood in detail. [21, 24, 25]
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In general, toxins are subdivided into three classes, namely 1) small molecular weight (MW)
water-soluble compounds, 2) protein-bound compounds, and 3) larger MW compounds or
“middle molecules”, such as polyelectrolytes. [26] It has been recognized that several protein-
bound toxins mainly bind to HSA. [22, 24, 27] When bound the the protein, these toxins
will inhibit its drug binding ability and may even lead to structural modifications. [25, 27,
28] Removal of these small hydrophobic molecules by dialysis is difficult as they bind tightly
to HSA. [29] Recently, Jankowski and coworkers [23, 30] have demonstrated that raising the
ionic strength in the infusion fluid leads to an improved clearance of protein-bound toxins
(PBT). Thus, raising the concentration of NaCl to 600 mM led to a significantly better
removal of uremic toxins as, for instance, phenylacetic acid. [30] This result points clearly to
the central importance of Coulombic interactions for the binding strength of such toxins to
HSA and to proteins in general. Up to now, only a few studies have explored the dependence
on temperature. [31–34] Much less is known about the dependence of the binding strength
on ionic strength in detail. [33, 35] Thus, the insufficiency of conventional dialysis in the
removal of protein-bound toxins presents a major challenge and improving renal dialysis by
solving this problem is thus a central task of clinical nephrology [30, 36]. For this purpose
a thermodynamic understanding of the interaction of toxins with HSA is absolutely necessary.
In the present thesis, the binding of two representative protein-bound uremic toxins to HSA
is investigated. Both of them are small hydrophobic molecules bearing an ionic moiety
(see Figure 1.1). Phenylacetic acid (PhAA) is a toxin that has not yet attracted much
attention so far. However, quantitative experiments using equilibrium dialysis (ED) and
chromatographic methods have shown that a considerable amount of PhAA is present in
dialysis patients prior and after dialysis. [22, 29, 30] The importance of ionic contributions
to the binding of this toxin is obvious from the fact that a more effective clearance of PhAA
can be reached by raising the ionic strength. [30] Indoxylsulfate is studied as a second toxin
because it bears a strong acidic (SO−4 ) group. Hence, a comparison of the thermodynamic
data of PhAA bearing a weak acidic group (COO−) with the ones obtained from IDS can
reveal details of the ionic interaction and its relation to toxin binding.
It is furthermore known from literature that HSA is modified in pathophysiological condi-
tions caused by chronic renal failure. [37] The concentration of urea is chronically elevated
in patients with renal failure and the subsequent protein modification was identified as
risk factor for mortality. [38] Urea-induced carbamylation of HSA on multiple lysine- and
arginine-containing chains were found, but the mechanisms of how it contributes to disease
is unclear. [39] A hypothesis to be investigated is that the modification of serum albumin
might affect binding affinities of uremic toxins and therefore impair its dialysis condition
and its subsequent chronically elevated plasma concentrations. The present study therefore
explores the effect of urea-modification on binding affinities of PhAA and IDS to HSA and
their structure upon complex formation.
Polyelectrolytes (PEs) can be seen as a model for larger MW and charged toxins interacting
with proteins. [26] The interaction of long linear polyelectrolytes with proteins in aqueous
solution has been the subject of long-standing research that has led to an enormous amount
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Figure 1.1: Pictural illustration of HSA interaction with different ligands. HSA crystal structure
is shown in surface representation, with red being acidic and blue basic amino acids. Dark grey
surface represent non-polar residues. PAA and IDS are represented using VDK spheres with
equivalent colour coding.
of literature. [40–43] Protein can form complex coacervates with polyelectrolytes of opposite
charges in aqueous solution and the strength of the interaction is mediated by the ionic
strength in the system. [44] If the ionic strength of the system is low enough, interaction
may take place even on the “wrong side“ of the isoelectric point, that is, proteins associate
with PEs of like charge. In many cases the formation of complexes between the protein and
the polyelectrolyte is accompanied by multiple binding processes and can lead to aggrega-
tion. [16, 41, 45] This effect however, do not occur for short PEs with only 25 repeating
units. Thus in the present thesis, the interaction of a low molecular weight polyanion,
polyacrylic acid (PAA), with HSA of same net charge is analyzed (see Figure 1.1). PAA is
a biocompatible polyelectrolyte and has been grafted onto planar or curved surfaces to form
polyelectrolyte brushes to allow, for instance, enzyme immobilization. [46–48] Using this
polyanion, the Coulombic interaction of a protein with charged molecules can be explored
to understand the forces that overcomes the simple picture of monopole-monopole repulsion
and consequently leads to binding. Furthermore, complementary computer simulations can
give additional insight into the binding site and the free energy of binding that can then be
compared to experimental results. The different binding contribution are better understood
by varying ionic strength and temperature in the system.
A number of techniques have been applied to elucidate the interaction between proteins and
ligands/polyelectrolytes. Often used methods to investigate binding affinities of protein-
ligand and protein-polyelectrolyte interaction are, for instance, equilibrium dialysis (ED),
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ultracentrifugation (UC) and calorimetric methods. [49] Among those, a technique that
has been excessively applied to study protein uptake into nanoparticles in terms of binding
affinity and thermodynamic signature, is isothermal titration calorimetry (ITC). [50, 51]
The major advantage of ITC is that it can access crucial thermodynamic information
such as enthalpy, entropy and binding free energy. [52] A first study of the interaction of
polyelectrolytes with proteins by ITC has been presented by Schaaf et al. who demonstrated
the general suitability of this method for the study of protein-polyelectrolyte interaction. [53]
Henzler et al. have also used ITC to acquire thermodynamic information of protein binding
to SPBs. [54] In a study of β-lactoglobulin adsorption to a SPB at different ionic strengths,
they identified the driving force that overcomes charge repulsion between the like charged
protein and SPB. Furthermore, a number of ITC-studies explore the dependence of the
adsorption constant on ionic strength. [45, 50, 55, 56] Additionally, ITC has been recog-
nized as an effective method to study protein-ligand binding and is seen as an important
tool applied in the field of drug design. [57, 58] Thus, in the present thesis, ITC is used
to obtain the binding constant and the number of bound ligands/polyelectrolytes per protein.
Calorimetry alone, however, does not reveal any structural information on the complex.
Spatial information can be accessed by crystallography [58, 59], small-angle scattering
(SAS) [60–62], Fourier-transformed infrared spectroscopy (FTIR) [63] and dynamic light
scattering (DLS) [16]. SAS is a well suited technique to study complexation of macro-
molecules in solution, where experimental conditions closer to actual physiological conditions
can be performed (e.g. physiological pH and temperature). [64–66] It is a technique widely
used to elucidate spatial structure of e.g. protein polyelectrolyte complexes. [67–70]
Proteins in general have a good contrast to heavy water and thus neutron scattering is
particularly useful to collect scattering data. The coacervation of protein-polyelectrolyte
complexes has been investigated using small-angle neutron scattering (SANS), where differ-
ent structures evolve by varying the pH of the solution and thus changing the effective net
charge of both protein and PE. [71] In another study, the adsorption of bovine hemoglobin
onto spherical polyelectrolyte brushes (SPB) was monitored by combining small-angle
X-ray scattering (SAXS) with FTIR and the distribution of protein within the SPB were
characterized. [63] In the present thesis, SANS is used to study protein complexation with
ligands and PEs in solution by pushing the technique to its limits of resolution and thus
investigating possible structural changes of the protein upon adsorption.
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The study presented in this thesis is dedicated to explore the binding contribution of ligand
and polyelectrolyte (PE) binding to human serum albumin. A model polyelectrolyte and two
small molecules were chosen to elucidate the Coulombic and the hydrophobic contribution
to interaction. The short chained PE, polyacrylic acid (PAA) interacts attractively with
HSA beside their negative charge at a pH above the pI of the protein. The ligands are
two representative uremic toxins, which are small molecules composed of an aromatic
hydrophobic moiety bearing an ionic group. While the first system explores the driving force
that overcomes monopole-monopole repulsion, the second system is medically relevant and
particularly interesting in the field of nephrology. Systematic investigations by combining
thermodynamic analysis with spatial information of the complexation process allows an
in-depth understanding of different contributions to interaction.
The thesis is organized as follows:
The subject of the present thesis is introduced in Chapter 1 with respect to its general
scientific relevance and a brief overview of related research is given.
Chapter 3 and 4 introduces basic physical principles and experimental methods used in
this thesis and provides a brief review of literature on the system studied.
In Chapter 5, a thermodynamic study on the interaction between PAA and HSA is
combined with SANS experiments to explore their structure in solution and compared to
pure HSA structure under various conditions. The thermodynamic results are compared to
computer simulation studies done by Xiao Xu, who uses a coarse-grained based model of
both interacting partners in a dielectric background. The combination of experiment with
theory gives an in-depth understanding of driving forces to binding.
Chapter 6 evaluates the binding of the uremic toxins to HSA by combining again ther-
modynamic studies with structural investigations. Calorimetric experiments comprising a
series of temperature and ionic strength measurements were performed to explore different
contribution to binding and main driving forces were identified. SANS experiments in high
concentrated solutions reveal the impact of toxin adsorption on the interaction between the
proteins in solution. Furthermore, the effect of modification of the protein, as is found in
pathological conditions, on the binding affinities of the toxins were explored.
Finally, Chapter 7 summarizes the results of the thesis and elaborates on the relevance of
the present study for future developments.
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3 Fundamentals
3.1 Protein - ligand/polyelectrolyte interaction
In the following chapter, reversible protein ligand/polyelectrolyte interaction will be dis-
cussed, where complex formation is noncovalent and the ligand associate and dissociate
in a thermodynamic equilibrium. Ligands can be small molecules, such as metabolites or
larger molecules, such as nucleic acids that form complexes with a biological macromolecule
such as a protein. Proteins are macromolecules consisting of chains of amino acids with
individual sequences that enable highly specific functionality. As such, proteins perform
a vast array of functions within organisms. For instance, antibodies attach to viruses or
bacteria to mark them for destruction. [72] Cellular signal cascades involve small molecular
messengers, transmitted by receptors to finally reach the functional response of a series of
molecular recognition processes. [73] The ability to selectively interact with high affinity to
a ligand is a result of the sum of multiple interaction contributions, such as electrostatic,
van der Waals and hydrophobic interactions. These interactions are enhanced by specific
surface contours and conformation of a protein towards certain ligand molecular structures.
However, complex formation in biological systems, can be driven by both specificity or
affinity. Unspecific binding can occur for instance in pathological conditions, where small
toxins in blood adsorb onto proteins and thus inhibiting their biological function. [26]
The protein under investigation in this study is Human serum albumin (HSA). The following
chapters are dedicated to the functionality and importance of HSA in the human body and
its interaction with various ligands and polyelectrolytes.
3.1.1 Human Serum Albumin (HSA)
Human serum albumin (HSA) is the most abundant protein in blood plasma, accounting
for nearly 60 % of the total protein in blood serum and showing a typical concentration in
blood of 30−50 g/L. [74] Albumin, which is synthesized in the liver, is a soluble, monomeric,
globular protein with a molecular weight (MW) of ≈ 64 kDa and an isoelectric point (pI) of
4.6. [19] HSA has an exceptional binding capacity for a wide variety of hydrophobic ligands
and plays a key role in the transport of hormones, fatty acids, amino acids, metals such as
Cu2+ and Zn2+, metabolites and pharmaceutical drug compounds. It is therefore believed
that HSA is the most essential carrier protein to transport water-insoluble solutes in the
bloodstream to target organs such as the liver, intestine, kidney and brain. [75] Beside its
role as a transport protein, HSA also contributes significantly to the pH regulation and
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osmotic blood pressure. [76]
HSA has been subject to extensive investigations over several decades in terms of its
physiological and pharmacological properties. [77, 78] A high resolution crystal structure
(2.5 Å) of fat free HSA was published in 1999 by Sugio et al. and is available in the
pdb-database (pdb-ID:1AO6). [75] HSA is a single polypeptide chain stabilized with 17
disulfide bridges between the total 585 residues. These form three homologous domains
(I, II and III) with each domain made up by two separate helical subdomains (A and B),
connected by random coil. The in total six subdomains assemble to form a heart-shaped
molecule (see Fig. Figure 3.1). [74]
Albumin is known for its extraordinary capacity to reversibly bind different classes of
ligands and toxins to multiple sites. [18, 19, 59, 79–81] Two most prominent binding sites
are named Sudlow I and Sudlow II located in the subdomains II-A and III-A, respectively
(see Fig. Figure 3.1). [82] Both sites contain deep pockets lined with hydrophobic side
chains with their entrance surrounded by positively charged amino acid residues. [75] The
interior of Sudlow I is predominantly apolar containing only two clusters of polar residues,
both positively charged. Sudlow site II can be distinguished from Sudlow I, as it has a
larger solvent accessibility area at its entrance and there is only one single main basic
polar patch, located at one side of the entrance. As a result, bulky heterocyclic anions
preferably bind to Sudlow I, whereas Sudlows II accommodates aromatic carboxylates or
other aromatic compounds. [19, 82] At the same time, those binding sites are the most
active and accommodating for drugs on HSA. [83]
Figure 3.1: Crystallographic representation of HSA complexed with fatty acids/ligands. Adapted
from [19].
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3.1.2 HSA - ligand binding
Beside its capability to bind many different ligands, HSA is also known to adsorb small
toxins, which occur in blood in pathological condition. [22, 24, 27] Among those, well studied
toxins and their interaction to HSA are p-cresyl sulfate (PCS), hippuric acid (HA) and
indoxyl sulfate (IDS). [25, 27, 28] Ghuman et al. have investigated drug-binding specificity
of HSA using crystallographic analysis. [84] For several drugs and also uremic toxins, the
group identified residues that are key determinants of binding specificity of the two Sudlow
binding pockets. [84] Depending on the polarity and electrostatic properties of the ligand,
hydrogen-bonds or salt-bridges can stabilize their binding to a protein. In the case of IDS, a
total of four hydrogen-bond or salt bridges are formed during binding at Sudlow II, with its
indole amide group interacting with the carbonyl oxygen of Leu430 (see Figure 3.2). Again,
binding affinities for IDS to HSA are found to be rather strong ∼ 105 − 106 mol−1. [24, 85]
Figure 3.2: Binding sites of HSA complexed
with IDS. The color code of the α-helices
corresponds to different subdomains. IDS
and selected side-chains are shown in stick
representation with semitransparent van
der Waals surfaces. The sticks are colour-
coded by atom type: carbon - orange; oxy-
gen - red; nitrogen - blue; chlorine - green.
Yellow dashed lines indicate hydrogen-
bonds. Adapted from [84].
There are a series of methods to study binding affinity between various ligands to HSA. [49,
86, 87] Yet, the results obtained by different methods can differ by orders of magnitude and
care must be taken, when comparing binding affinities derived from different experiments.
A set of well studied examples for the binding of common ligands to HSA investigated by
different techniques is listed in Table 3.1. Typically, studies are conducted at either room
(25 ◦C) or body temperature (37 ◦C) and pH 7.4. [27, 88]
The binding of uremic toxins have been investigated by different experimental techniques
and a comparison of results is shown in Table 3.1. The interaction of IDS and PCS with HSA
was studied using equilibrium dialysis (ED), ultrafiltration (UF), liquid chromatography
(LC) and ultracentrifugation (UC). Different Kb were obtained depending on the experiment
performed. These separative methods used are based on differences in molecular size and/or
weight and thus they are very fast and easily performed. However, unwanted interaction
of protein or ligand with the membrane necessary for these methods is unavoidable and
protein leakage may arise. [89] Furthermore, physical phenomena such as back diffusion
and viscosity effects may influence the determination of free ligand concentration and thus
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significant discrepancies occurred when comparing results obtained by ED and UC. [90]
Another approach to analyze protein ligand binding using non-separative methods are
spectroscopic techniques such as fluorescence spectroscopy (FS), nuclear magnetic reso-
nance (NMR), circular dichroism (CD), and many more. These methods are based on the
perturbation of the electronic energy levels of either the ligand or the protein upon binding.
The adsorption of the uremic toxin hippuric acid (HA) to HSA was investigated comparing
ITC and steady state fluorescence quenching (SSFQ). [31] The binding affinity obtained
under different temperatures differ by about one order of magnitude (see Table 3.1). While
ITC can detect two binding processes, only one binding site was detected by SSFQ. The
authors remark that binding affinities obtained by SSFQ may be influenced by the quencher
fluorophore and thus rely more on ITC in determining Kb. [31].
Two more examples of well studied anti-inflammatory drugs are ibuprofen and naproxen,
both negatively charged at neutral pH [88] and reported to bind preferable to the Sudlow
site II (see Table 3.1). [82, 84] Binding affinities of ibuprofen adsorption to HSA obtained
by ITC from different authors are comparable in magnitude[88, 91], the values obtained by
difference circular dicroism (DCD) and affinity capillary electrophoresis (ACE) are an order
of magnitude smaller. [92, 93]
With a wide range of experimental possibilities, the selection of an appropriate method
depends on the type of information desired. A comparison of the different ranges of Kb
and information that can be accessed with some commonly used methods limitations and
advantages are presented in Table 8.2 in the Appendix. Among these methods, ITC combine
the ability to obtain reliable binding affinities with the benefit of providing information on
enthalpy and entropy. Furthermore, both ionic strength and temperature were found to influ-
ence the interaction between protein and ligand. Thus, for a comprehensive thermodynamic
understanding of the interaction, it is necessary to perform experiments combining a set of
temperature and ionic strength measurements to explore different binding contributions.
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Table 3.1: HSA interaction with different ligands, investigated by different techniques in the literature.
Ligand Chemical structure Methods∗ T (◦C) I (mM) Kb1 (103 M−1) N1 Kb2 (103 M−1) N2 Reference
Ibuprofen
ACE 25 50 24 - - - [92]
FS 25 50 2.4 - - - [94]
ITCa) 25 50 900±100 0.84 - - [88]
ITCa) 25 50 303 1.1 - - [91]
DCD 37 50 14 - 36 - [93]
CE/FA 37 67 710 1.0 14 7.6 [95]
Flurbiprofen
ITC 25 50 5000±3000 0.7 (60±40) 4.8 [88]
CE/FA 25 50 - - 35±3 5.0±0.1 [88]
ED 37 66 1200 - 140 - [96]
ED 37 67 1380 1.19 8.98 7.7 [97]
Hippuric acid
SSFQ
25 20 6.8±0.2 0.98 - - [31]
30 20 3.1±0.2 0.99 - - [31]
37 20 1.04±0.01 0.97 - - [31]
ITCb)
25 20 28±0.5 1 2.8±0.5 1 [31]
30 20 25±1 1 1.38±0.03 1 [31]
37 20 15±1 1 1.29±0.07 1 [31]
Indoxyl sulfate
EDc) 25 67 910±290 1 8±4 3 [24]
ED/UCc) 25 67 1610 1 8.3 3 [27]
LC 30 150 57±2 - - - [98]
UFc) 25 150 98 1 8 1.6 [85]
ED & UFe) 24 150 10.2 2.7 - - [25]
P-cresyl sulfate
EDc) 25 67 910±290 1 8±4 3 [24]
ED& UFe) 24 & 37 150 17.7 2.9 - - [25]
ACE: Affinity capillary electrophoresis, ED: equilibrium dialysis, CE/FA: capillary electrophoresis/frontal analysis, DCD: difference circular dicroism, FS: fluorescence spectroscopy, ITC:
isothermal titration calorimetry, SSFQ: steady state fluorescence quenching, LC: liquid chromatography, UF: ultrafiltration, UC: ultracentrifugation.
Binding equilibrium data/isotherms were analyzed using a) model for one set of identical sites, b) sequential binding mode for two independent sites, c) a model of binding of two ligands to one
protein with two different and independent sites m, d) an one site specific binding model, e) Hill analysis
All experiments listed here were performed at pH 7.4
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3.1.3 Protein - polyelectrolyte interaction
Interactions of polyelectrolytes (PEs) with proteins and the formation macromolecular
complexes is a subject extensively studied with a wide range of applicability in medical
and pharmaceutical areas such as drug delivery [3, 99, 100], nanodevices and sensors [101,
102], protein purification [16, 43], and enzyme immobilization [56]. As proteins are charged
colloidal particles, they can interact electrostatically with DNA, RNA and polyelectrolytes
and thus forming soluble complexes. [17, 103, 104] An electrostatic picture of the protein
will depend on solvent pH as many amino acid residues are zwitterions. Studies by Dubin et
al. showed that complexation between synthetic polyelectrolytes and globular proteins show
at least three different phases of interaction as a function of pH and salt concentration in
the solution (see Figure 3.3). [42, 55, 105, 106] In the case of e.g. a negatively charged PE,
at least three states: (i) above a critical pHcrit, electrostatic repulsion prevent interaction
between protein and polyelectrolyte, (ii) below pHcrit, soluble aggregates are formed and
(iii) a further decrease of pH will lead to macroscopic phase separation of an insoluble
complex. In case of weak polyelectrolytes, an additional phase can occur for even lower pH,
where the PE is neutralized. [107] The phase diagram sensitively depend on salt concentra-
tion in the system as an electrostatic screening comes into play with increasing salt. [108–110]
Figure 3.3: Phase diagram of weak polyacid interacting with globular proteins as a function of
pH and salt concentration. More than three states of interaction can exist depending on the
system: (i) absence of interaction above pHcrit, (ii) soluble complex formation, (iii) coacervation
and an one-phase region coexist where the charge of the weak PE is neutralized. This phase
does not exist for strong PEs. Adapted from [107].
It has also been recognized that interaction can occur at the “wrong side of pI”, where proteins
interact with polyelectrolytes while both bearing the same sign of charge (see Figure 3.3). [42,
111, 112] This means that attractive interaction exists that overcomes monopole-monopole
repulsion of charges. An explanation is found in the heterogenous charge distribution of
proteins, that is, for instance positive charges are assembled to patches on the protein, while
the overall net charge is negative. These patches act as multivalent counterions to PEs and
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thus overcome repulsion. [104, 113, 114] Upon interaction, counterions previously condensed
on the PE chains are released and contribute significantly to a favorable change of entropy
in the system. This effect is known as the counterion release force and has been observed for
the binding of proteins onto spherical polyelectrolyte brushes. [17, 54, 115] In several studies
on PE-protein coacervation and aggregation, binding processes were also entropically driven
and considered as the main driving force for complexation at the “wrong side of pI”. [16,
45, 110, 116] The release of ions involving polyelectrolyte association to form a complex
is described by Record and Lohman and will be discussed in more detail in Section 3.2.3. [117]
Theoretical studies explore the interaction between a single, highly charged PE chain with
like-charged patchy protein models and give clear proof of the counterion release force. [118]
Snapshot of computer simulations by means of Langevin dynamics with implicit solvent and
explicit ions is shown in Figure 3.4. [118] The protein is modeled as a charged patchy particle
(CPPM) and is represented by a yellow sphere with a white patch in Figure 3.4. Negative
charges are red and distributed over the CPPM and positive charges are blue and located
within the patch. This patchy distribution leads to a dipole moment of the order of 102-103
Debye as typically found for proteins. The PE consists of 25 monomers, each bearing one
negative charge, represented by orange beads. Positive ions represented as green beads
are seen to be condensed on the PE prior to adsorption (Figure 3.4A). Figure 3.4B shows
the PE chain adsorbed onto the positive patch of the protein as charge-dipole attractions
dominate in short distances over the monopole repulsion, as seen by other studies. [119,
120] The main contribution originates from the counterions released upon binding, leading
to an increase of the entropy in the system and a concomitantly negative contribution to
the free enthalpy of binding.
To study the influence of charge-charge interaction experimentally, it is essential to explore
the influence of salinity on binding. It has been argued that electrostatic interactions are
completely screened under physiological condition where the ionic strength is of the order
of 150 mM. However, binding may still prevail beside high salt concentrations and a central
point of this thesis is to gain a detailed understanding of driving forces for binding by a
direct comparison of experiments with simulations.
Figure 3.4: A) Exemplary snapshot of a CPPM with a highlighted white patch where blue spots
mark the positive charges interacting with a negatively charged PE (orange beads) with explicit
salt ions (green beads represent positively and red negatively charged ions) in a center-to-center
distance r. B) Representative snapshot of a case where the PE chain is fully adsorbed onto the
protein patch. Adapted from [118].
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3.2 Binding thermodynamics of ligands to proteins
In the following section, a few of the physical models underlying the analysis of the ITC
results collected in the present study will be presented, while details may be found in other
literature. [72, 121–124]
3.2.1 Binding to a single set of identical sites (SSIS)
In the simplest case of a binding equilibrium, where the protein P has only one binding site
and a single ligand L binds, the binding process can be expressed:
P + L Kb←−−−−→ PL with Kb = [PL][P ][L] (3.1)
where Kb is the binding constant and characterizes the affinity of binding. In experiments,
binding isotherms are measured and a binding parameter b can be obtained either directly
or indirectly. b is defined as the average number of ligand molecules that are bound per
protein and covers a range from 0 to n, where n is the number of binding sites per protein,
therefore yields:
b = [L]b[P ]t
= [PL][P ] + [PL] =
Kb[L]
1 +Kb[L]
(3.2)
where [L]b is the concentration of bound ligand, [L] the free ligand concentration, [P ]t the
total protein concentration, [P ] the free protein concentration and [PL] the concentration
of ligand-protein complexes. A different, experimentally accessible binding parameter
(indirectly measured by e.g. ITC), is the saturation fraction Θ, which gives the fraction of
binding sites occupied by a ligand. It is related to b by Θ = b/n, where n is the number of
free binding sites and ranges from zero to one at full occupancy. Equation (3.2) can then
easily be extended for the case that n identical sites exists on the protein by multiplication
with n and thus simply replacing b with Θ:
Kb =
Θ
(1−Θ)[L] (3.3)
This is the Langmuir adsorption isotherm which describes the adsorption of gas
molecules on surfaces. [121] In an ITC experiment, only the total concentration of lig-
and [L]t in the solution is known and the free ligand concentration [L] is connected to [L]t
as followed:
[L]t = [L] + nΘ[P ]t (3.4)
Combining Equation (3.3) and Equation (3.4) gives:
Θ2 −Θ +
[
1− [L]t
n[P ]t
+ 1
nKb[P ]t
]
+ [L]t
n[P ]t
= 0 (3.5)
The total heat of adsorption Q is measured in an experiment as a differential heat Q′
divided by the moles of ligand in the j-th titrant injected dlj with dlj ≈ Vt · d[L]t. The
differential heat Q′ can be expressed in general as a differential equation: [125]
Q′ = dQ
Vt · d[L]t =
n∑
m=1
∆Hm
d[PLm]
d[L]t
(3.6)
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where n is the number of binding sites, Vt the cell volume and ∆Hm the molar heat of the
reaction. For the SSIS model, the expression for Q reads:
Q = nΘ[P ]t∆HITCVt (3.7)
with ∆HITC as the total enthalpy of the system measured by ITC. Solving the quadratic Equa-
tion (3.5) for Θ and substituting this into Equation (3.7), one obtains:
Q([L]t) =
n[P ]t∆HITCVt
2
1− [L]t
n[P ]t
+ 1
nKb[P ]t
−
√(
1 + [L]t
n[P ]t
+ 1
nKb[P ]t
)2
− 4[L]t
n[P ]t

(3.8)
In the continuum limit, the derivative dQ([L]t)/d[L]t with respect to Vt is given by the
following equation:
Q′ = dQ
Vt · d[L]t =
∆HITC
2
1− −1 + [L]tn[P ]t + 1nKb[P ]t√(
1 + [L]tn[P ]t +
1
nKb[P ]t
)2
− 4[L]tn[P ]t
 (3.9)
The fitting of the experimental data is performed by calculating the incremental heat Q′
released with each titration using manually set initial values and comparing these values
with the measured isotherm. The initial values are then compared with the measured
isotherm and improved by using the standard Marquardt method. These steps are repeated
until a satisfactory fit is achieved. Q′ is given by: [126]
Q′i = Qi +
dVi
Vt
[
Qi +Qi−1
2 −Qi−1
]
(3.10)
Manually set initial values are used to compare with the measured isotherm.
3.2.2 Binding to two sites
In the following, two models describing the binding of ligands to two independent binding
sites with different affinities is presented.
3.2.2.1 Sequential binding to two different, independent sites (SBS)
In the sequential model, binding affinities are defined relative to the progress of saturation,
that is binding at one site takes place relative to the progress of the other site. The model
furthermore assumes that for each step, only one ligand is bound to the according site.
There are two different but equivalent ways describe the binding process. [123] A schematic
depiction is given in Figure 3.5 to illustrate the difference between the two approaches.
1. Binding takes place in two steps, where the first equilibrium process is the binding
of one ligand to one site of the protein, described by the binding constant kb1. The
second step is the binding of a second ligand to the second site (accordingly described
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by kb2) thus achieving saturation. For each equilibrium step, a binding constant can
be defined:
P + L kb1←−−−−→ PL PL+ L kb2←−−−−→ PL2 (3.11)
kb1 =
[PL]
[P ][L] kb2 =
[PL2]
[PL][L] (3.12)
2. Binding equilibrium exists between both free and bound ligand with either one or
two bound ligand molecules. The equilibrium formula for this case is related to the
one above as follows:
P + L β1←−−−−→ PL P + 2L β2←−−−−→ PL2 (3.13)
β1 =
[PL]
[P ][L] = Kb1 β2 =
[PL2]
[P ][L]2 = Kb1 ·Kb2 (3.14)
Figure 3.5: Schmatic depiction of the sequential binding model. The binding of two ligands
(brown triangles) to the protein (turquoise forms) incorporating two different binding sites can
be described following two approaches. The steps labeled with kbi are described in the first and
the binding equilibrium labeled with Kbi in the second point above.
The total ligand concentration [L]t in Equation (3.4) introduced in the SSIS model becomes:
[L]t = [L] + [P ]t
 [L]kb11 + kb1[L] + kb1kb2[L]2︸ ︷︷ ︸
F1
+ 2kb1kb2[L]
2
1 + kb1[L] + kb1kb2[L]2︸ ︷︷ ︸
F2
 (3.15)
defining the two sums in the brackets as F1 and F2 accordingly, it follows for the total heat
Q:
Q = [P ]tVt (F1∆H1 + F2[∆H1 + ∆H2]) (3.16)
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3.2.2.2 Binding to two sets of independent sites (TSIS)
A different formalism to describe a two-sites model compared the approach above, is to
define two sets of parameters for each site, namely two binding numbers ni, enthalpies ∆Hi
and microscopic equilibrium constants kbi. Binding is described by the following reaction:
P + (n1 + n2)L
kb1kb2←−−−−−−→ PLn1+n2 (3.17)
each binding constant is defined as in Equation (3.3):
kb1 =
Θ1
(1−Θ1)[L] kb2 =
Θ2
(1−Θ2)[L] (3.18)
and the binding parameter is expressed as:
b = n1Θ1 + n2Θ2 =
n=2∑
i=1
niki · [L]
1 + ki · [L] (3.19)
In contrast to the SBS model introduced in Section 3.2.2.2, kb1 and kb2 are microscopic
binding constants describing the binding affinity of a ligand to the corresponding site. In
this model, six free parameters are involved. Namely for each site two enthalpies ∆HITCi ,
binding numbers Ni and binding constants kbi respectively. Thus fitting must be carried
out carefully with respect to using to many free parameters.
3.2.3 Basic thermodynamic relationships
ITC can provide a full set of thermodynamic information, such as binding affinity Kb,
stoichiometry n and the change of enthalpy (∆Hb), entropy (∆Sb) and free energy (∆Gb)
of interaction. While ∆H, n and Kb are directly measured quantities, the Gibbs free energy
∆Gb can be calculated as follows: [72]
∆Gb = −RT · lnKb (3.20)
where R is the universal gas constant. Another fundamental equation linking free energy,
enthalpy and entropy is:
∆Gb = ∆Hb − T∆Sb (3.21)
The dependence of the binding free energy on temperature is given by:
∆G(T ) = ∆H(T0) +
∫ T
T0
∆CpdT − T∆S(T0)−
∫ T
T0
∆CpdlnT (3.22)
where T0 is an appropriate reference temperature and ∆Cp is the heat capacity change that
is derived by the partial derivative of enthalpy with respect to temperature at constant
pressure:
∆Cp =
(
∂∆H
∂T
)
p
(3.23)
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For the case where ∆Cp is constant in the temperature range of interest, Equation (3.22)
simplifies to:
−RT lnKb = ∆G(T ) = ∆H(T0)− T∆S(T0) + ∆Cp
[
T − T0 − T ln
(
T
T0
)]
(3.24)
Here, both enthalpy and entropy depend on temperature through the change of heat capacity.
Dividing Equation (3.24) by T and taking the derivative with respect to 1/T yields the
van’t Hoff analysis:
−R∂lnKb
∂( 1T )
= ∆H0vH + ∆Cp(T − T0) (3.25)
where we define ∆H0vH = ∆Hb as binding enthalpy. In many systems, ∆Cp can be
diminishing, such that the approximation ∆Cp ≈ 0 holds and the van’t Hoff relation yields:(
∂lnKb
∂T−1
)
p
= −∆Hb
R
(3.26)
From this equation, ∆Hb can be obtained from the slope of the linear fit and ∆Sb from the
intercept of the integrated form:
lnKb = −∆Hb
RT
+ ∆Sb
R
(3.27)
In Section 3.1.3, the entropic contribution of the counterion release force was discussed, as
observed in polyelectrolyte complexation with proteins. This phenomenon was considered
many years ago by Record and Lohman who predicted a linear correlation between the
logarithms of binding constant Kb and salt concentration in solution cs: [117]
d lnKb
d lncs
= −∆Nion (3.28)
where ∆Nion is the number of ions released into bulk upon binding. In the case of a positive
protein patch interacting with a negative polyelectrolyte, negative and positive counterions
∆N± can be released respectively. This favorable entropic contribution leads directly to a
negative contribution to the free energy of binding and the according change ∆Gcr is given
by: [54]
∆Gcr =
∆N−
kT
ln
(
cs
cpatch
)
+ ∆N+
kT
ln
(
cs
cPE
)
(3.29)
where cpatch is the concentration of negative counterions accumulated on the positive patch
and cPE the surface concentration of positive condensed ions of the PE. Depending on
the ratio between the counterion concentrations of PE and protein, and the total salt
concentration, the free energy contribution can be significantly large.
3.3 Small-angle neutron scattering (SANS)
Small-angle neutron scattering (SANS) is a non-destructive technique to characterize
structures with sizes varying from several Ångströms to a few hundreds of nanometers.
Thereby, one takes advantage of the fact that changes in the scattering angle of the neutron
are related to structural properties of the sample. In the following chapter, a brief summery
of the basics of small-angle scattering is given. [127–129]
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3.3.1 General theory
Figure 3.6 shows a scheme of a scattering experiment. An incident beam of neutrons with
the wave vector ki and the wavelength λ = 2pi/|ki| is scattered in a single and elastic
process such that |ki| = |ks| holds. The scattered wave ks is emitted with a fixed phase
relationship to ki with an angle of 2θ. The resulting scattering vector q is defined as:
q = ki − ks and |q| = 4pi
λ
sin(θ) (3.30)
Figure 3.6: Schematic depiction of a small-angle scattering experiment. (a) The geometrical
representation of the experiment shows an incident beam ki that is scattered by a sample and
arrives at the detector as ks under the scattering angle 2θ. (b) The difference of incident and
scattered wave gives the scattering vector q.
The common way to describe the scattering is to start with the incoming wave with the
amplitude A0 that is scattered by a particle i at the location ri. The emitted wave A(q) is
then the sum over all amplitudes scattered by the particles in solution:
A(q) = A0 ·
∑
i
bie
−iqri (3.31)
where bi is a value depending on interaction between the radiation and the scattering
particle and will be specified later. The discrete scattering centers can be approximated
by a continuous scattering length density (SLD) function ρ(r) within the sample volume
V with the assumption of small scattering angles and thus transfer the above sum into an
integral over V .
A(q) =
∫
V
ρ(r)e−iqrdr (3.32)
This integral can be identified as the Fourier transform of the SLD function ρ(r), which can
be split into a sum of a constant mean value 〈ρ〉 and a location-dependent part:
ρ(r) = 〈ρ〉+ δρ(r) (3.33)
The scattering of 〈ρ〉 contributes only in the forward direction q = 0 and therefore is
experimentally not detectable. Finally, the experimentally accessible quantity is the number
of detected neutrons that are scattered into a solid angle dΩ around a given direction which
gives the differential cross section dσdΩ . This quantity is related to the scattering intensity
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I(q) (i.e. the squared scattering amplitude), which in combination with Equation (3.32)
and Equation (3.33) yields:
dσ
dΩ ≡ I(q)/V = |A(q)|
2 = 1
V
∣∣∣∣∫
V
δρ(r)e−iqrdr
∣∣∣∣2 (3.34)
Normalizing I(q) to the sample volume V establishes the differential cross section in units
of so-called macroscopic cross sections cm−1 independent of the instrument and its sample
geometry.
For neutrons, the scattering length introduced in Equation (3.31) as bi, consists of a coherent
and an incoherent contribution:
dσ
dΩ = b
2
coh ·
N∑
ij
〈e−iq(ri−rj)〉+N · b2inc (3.35)
=
(
dσ
dΩ
)
coh
+
(
dσ
dΩ
)
inc
(3.36)
with the number of scatterers N at positions r. This equation demonstrates that the
information about form and spatial correlation of the scatterers is only contained in the
first term, while the second term only arises from fluctuations in scattering length b and is
independent of q. Again going to a continuous distribution of scatterers, we can write the
coherent SLD as:
ρcoh(r) =
∑
i
ρi(r)bicoh (3.37)
In the following equations, we assume an isotropic system in recognition of the fact that
the system contains a large number of particles oriented in random directions. It follows
that the intensity I(q) can be obtained by averaging the absolute square of A(q) over all
possible orientations of the particle and the vector q can be replaced by a scalar q.
3.3.2 Scattering of particles in solution
In a dilute system consisting of N particles in a volume V , the particles do not “sense”
their neighbors. Their positions are therefore uncorrelated without any fixed phase relation
between waves scattered by different particles. Thus, the overall intensity is simply the sum
of all particle scattering and normalized to the sample volume:
I(q) = (∆ρ)2 · N
V
〈[∫
VP
e−iqrd3r
]2〉
= (∆ρVP )2 · N
V
〈
[F (q)]2
〉
(3.38)
where VP is the particle volume, V the illuminated sample volume as defined before and
the contrast ∆ρ = ρp − ρs as the difference between SLD of particle and solution. Here,
we assume constant scattering length densities ρp for identical particles dispersed in a
continuous matrix of solution with ρs. F (q) can be identified as the particle form factor,
which contains information about the geometry of the individual scatterer.
In a more dense system of scatterers however, the positions of individual scatterers are no
longer independent and interference between waves scattered from neighboring particles
20
3.3 Small-angle neutron scattering (SANS)
Figure 3.7: Schematic comparison of scattering from dilute and concentrated solutions with ρp
and ρs as the scattering length densities of particle and solution respectively.
can occur. The difference compared to a dilute system is illustrated in Figure 3.7. As a
result, the above Equation (3.38) becomes:
I(q) = (∆ρVp)2 · N
V
〈
[F (q)]2
〉
S(q) (3.39)
where in experiments, a particle scattering term is often defined as P (q) =
〈
[F (q)]2
〉
. S(q)
is the structure factor, which describes the spatial correlation of N particles separated by
the distance r. S(q) is defined as:
S(q) = 1 + N
V
∫
4pir2[g(r)− 1] sinqr
qr
dr (3.40)
with g(r) as the pair correlation function.
A total correlation function can be defined h(r) = g(r)− 1 which describes the influence of
a particle 1 on a second particle 2 with a distance r in between them. The total correlation
function can be divided into a sum of a direct and an indirect part:
h(r) = c(r)︸︷︷︸
direct part
+n
∫
c(R)h(r −R)dR︸ ︷︷ ︸
indirect part
(3.41)
This equation is also known as the Ornstein-Zernike (OZ) integral, where the direct correla-
tion function c(r) needs to be determined. In the first term, c(r) yields the direct influence
of two neighboring particles and thus only depends on a short ranged interaction potential.
The second term gives the indirect interaction of a particle at position r via an intermediary
third particle at the distance R, given by the integral.
3.3.2.1 Structure factor for charged particles in solution
An analytical structure factor to describe the correlated scattering of macroions in solu-
tion was developed by J.B. Hayter and J. Penfold in the early 1980’s. [130] The present
paragraph aims to define basic principles and equations underlying the Hayter-Penfold
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Mean-Spherical-Approximation (HPMSA) that is used in this thesis to analyze interparticle
interaction between proteins in solution.
The macroion system by Hayter and Penfold is based on the following assumptions: (i) the
properties of macroions dominate the contribution towards interaction in solution and (ii)
the macroions can be described as charged spheres with a finite volume and interact via a
screened Coulomb pair potential. In such a case, the weak Van-der-Waals interaction can
be safely neglected. [130]
The Mean-Spherical-Approximation (MSA) [131] is based on the Debye-Hückel theory but
takes into account volume exclusion effects. Instead of a point mass, the spherical macroions
in solution have a diameter d and interact via the repulsive potential:
U(r) = pi0d
2ψ20
r
· e[−κD(r−d)], r > d (3.42)
where r is the distance between the macroions, ψ20 the surface potential,  the dielectric
constant of the solution and κD the above mentioned inverse Debye length. ψ20 depends on
the charge zm of the macroions and is given in good approximation by:
ψ0 =
zm
pi0σ(2 + κd)
(3.43)
In the following, we shall keep the notation Hayter and Penfold and define the dimensionless
variables:
x = r/d, k = κd, K = Qd (3.44)
The macroions are treated as hard spheres and the interacting potential can be written as
follows:
βU(x) =
γ/xe−kx, x > 1∞, x < 1 (3.45)
where β = 1/kbT . γe−k = ψ20 can be identified as contact potential between two ions in
units of kBT (this expression is true for k . 6).
Finally, using closure relations:
c(x) = −βU(x), x > 1 (3.46)
h(x) = −1, x < 1 (3.47)
the structure factor follows from the Fourier transform of the OZ equation
S(K) = 1/ [1− 24φa(K)] (3.48)
with the volume fraction φ of the proteins in solution and the dimensionless quantity K = qd.
a(K) is a rather complicated term depending on K and the details can be found in the
original publication. [130] The free fitting parameters are φ, the ionic strength in the system
I, the charge Z and the effective diameter of the protein d. These values are linked to the
structure factor by the following equations:
φ = pind
3
6 (3.49)
γ = z
2
m
(2 + κd)e
κd (3.50)
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with n as the density of macroions in solution and the charge valency zm = Z · e.
Examples of structure factors and the effect of the two most interesting quantities for the
present study are given in Figure 3.8. Here, the diameter d and the volume fraction φ are
set at fixed values of 50 Å and 0.02, respectively. The influence of effective charge Z of
the proteins in solution is shown in the top figure, where a correlation peak evolves with
increasing Z. This same peak (fixed to Z = 40 for the bottom panel) is suppressed by an
Figure 3.8: Effect of the parameters charge |Z|, ionic strength I and the diameter d on the Hayter
Penfold structure factor (HPMSA). In (a) the increase of |Z| from 5 to 40 is reflected in the
increase of the first maximum. (b) High ionic strength (150 mM) leads to a decrease of the first
maximum, as the interactions are screened. (c) A decrease of d from 140 Å to 60 Å shifts the
first maximum to larger q, which equals smaller dimensions in real space.
increase of ionic strength. Moreover, the increase of φ will result in an increase and shift of
the first peak towards higher q and inversely, the increase of d will shift the peak towards
lower q values.
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3.3.2.2 Guinier Law for dilute solutions
A general approach to characterize single particles in dilute solution without any prior
knowledge of the shape or regularity of a particle, is given by the Guinier Law. In the limit
of small q, the scattering function follows a certain universal form derived from the Taylor
expansion of the form factor term e−iqR and is described by:
I(q) ≈ N(∆ρVp)2exp
(
−13q
2R2g
)
(3.51)
The Guinier Law is valid for (i) scattering vectors qRg < 1.3, (ii) a dilute system of inde-
pendently scattering particles and (iii) an isotropic system of randomly orientated particles
with centers of symmetry. The above equation allows the determination of the radius of
gyration Rg of any particle and of the particle volume VP as demonstrated in Figure 3.9.
Rg gives the effective size of a scattering particle, irrespective of its geometry or shape.
The Guinier analysis is demonstrated on the example of scattering spheres with radius
R = 50 Å in Figure 3.9. The inset shows the logarithm of the intensity ln(I(q)) over q2
and the Guinier regime is indicated by a dotted line. The slope of the linear fit using Equa-
tion (3.51), gives a radius of gyration Rg = 38.9 Å. In the present case of homogeneous
spheres, Rg =
√
3/5R is valid and well obtained by the fit.
Figure 3.9: Theoretical scattering of spheres in solutions. The hardsphere form factor with
R = 50 Å is plotted as an example for the Guinier analysis. The inset shows a linear fit for the
Guinier regime of low scattering vectors in a ln(I(q)) over q2 plot.
The Guinier analysis is also a method to determine the forward scattering I(0) of a sample
and subsequently can be used to calculate the molecular weight of the protein, as the
following holds:
I(0) = N(∆ρVp)2 =
c∆ρ2ν2MW
NA
(3.52)
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where c is the macromolecule concentration in g/cm3, ν the specific volume and NA the
Avogadro’s number.
3.3.3 Contrast variation
As briefly mentioned above, contrast variation is a powerful tool, first introduced by
Stuhrmann and Kirste in 1965. [132, 133] The scattering length of the solution is varied,
thus changing the contrast ∆b of the scattering particles in the matrix. As a consequence,
two border cases exist, namely infinite contrast (∆b =∞) and vanishing contrast (∆b = 0).
The scattering length density (SLD) function defined in Equation (3.38) can be replaced by
an excess SLD function g(r, ρs). This function is split into a term depending on contrast
ρ¯− ρs and an independent term ∆ρ(r): [134]
g(r, ρm) = ∆ρ(r)− ρs = F (r)[ρ¯− ρm] + F (r)δρ(r) (3.53)
where F (r) is the form factor as introduced in Equation (3.38) and F (r)δρ(r) describes the
deviation of the particle’s SLD from its mean value. The average SLD ρ¯ is defined as:
ρ¯ = 1
Vp
∫ ∞
0
F (r)ρp(r)dr (3.54)
combining Equation (3.53) and (3.54), it is evident that:∫
F (r)∆ρ(r)dr = 0 (3.55)
The total scattering intensity I(q) is then calculated to:
I(q) = (ρ¯− ρm)2IS(q) + 2(ρ¯− ρm)ISI(q) + II(q) (3.56)
where IS(q) is the scattering contribution of a particle for infinite contrast, ISI(q) is a
cross term and II(q) comprises inhomogeneities of the scattering length within a particle.
An analogous Guinier analysis can be performed here for q → 0 as in Equation (3.51).
Equation (3.55) in conjunction with Equation (3.56) leads to: [135]
nI0(q) = n(ρ¯− ρsol)2 · V 2p = φ(ρ¯− ρsol)2 · Vp (3.57)
with the Guinier approximation:
I(q)
φ
≈ n∆(ρ¯− ρsol)2 · exp
(
−13q
2R2g
)
(3.58)
where n is the number density of monodispersed objects in the solution and Vp the volume
of that object. Thus, the volume fraction φ can be written as φ = nVp.
Furthermore, the radius of gyration Rg depends equivalently on contrast. Here, the radius
of gyration at infinite contrast Rg,∞ corresponds to the radius of gyration of the pure form
factor F (r). The dependency of Rg on the contrast for a centrosymmetric object is given
by: [132, 136]
R2g = R2g,∞ +
α · ρ¯
ρ¯− ρs (3.59)
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with
Rg,∞ =
1
Vp
∫ ∞
0
F (r)r2dr (3.60)
The coefficient α may be regarded as a measure for the spacial distribution of the inho-
mogeneity of the particle scattering length distribution. A positive value for α indicates a
higher SLD in the periphery of the particle while lower on the inside, and vice versa for
negative α values.
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4.1 Isothermal Titration Calorimetry (ITC)
Calorimetry is a sensitive technique to obtain thermodynamic information on binding
affinity, enthalpy and entropy simultaneously. Practically all biomacromolecular interactions
such as protein/ligand, protein/protein, and protein/nanoparticle are accompanied by
heat exchange. Isothermal titration calorimetry (ITC) can very precisely monitor this
change of heat under a constant temperature and adiabatic conditions in the range from
∼ 103−109 mol−1. The following Section discusses the basic principles of an ITC instrument
and presents an overview of its strengths and weaknesses in comparison to other techniques
that are employed to characterize ligand binding to proteins.
Experiments are performed using a VP-ITC instrument (MicroCal, GE Healthcare) by
stepwise addition of a ligand solution into the cell containing the protein solution. A
schematic representation of the ITC setup is shown in Figure 4.1. It consists of two identical
and thermally conducting cells enclosed in an adiabatic jacket and a stirring syringe reaching
into one of the cells. The ligand solution stored in the syringe is titrated subsequently under
constant stirring into the sample cell filled with protein solution.
The two cells are made of a highly efficient thermal conductive material that is inert to
many solvents. The sample cell has a working volume of 1.4 mL and the high-precision
stirring syringe can hold 280 µL of reactant, which can be injected in steps of few µL under
stirring at 307 rpm into the cell. Typical equilibration time intervals between each injection
are ∼ 280− 350 s.
The heat evolved or taken up in the mixing process is then detected by the sensitive
thermocouple circuits as a change of temperature compared to the reference cell, which is
kept constant at a certain temperature. This temperature change is calibrated to power
units and observed as a time-dependent input giving an incremental heat change dQ/dt(Q′)
in µcal/sec. To keep the temperature of the sample cell constant relative to the reference
cell, an either positive or negative change in the differential power (DP) feedback system is
necessary, depending on the temperature change ∆T in the system. An exothermic process
will for instance decrease the applied power, as heat is released and less power needed
to keep the temperature constant. A titration peak after each injection is observed and
drops back to a constant baseline after the system in the sample cell recovers equilibrium
(Figure 4.2 top). The integral over time of each titration peak then gives the incremental
enthalpy ∆Q of adsorption in cal/mol as a function of the molar ratio x between titrant
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Figure 4.1: Schematic depiction of isothermal titration calorimeter (ITC). Screened from the
environment by an adiabatic jacket are a sample cell filled with proteins and a reference cell
containing pure millipore water. Both cells are highly thermally conducting, thus temperature
can be precisely controlled and measured. A stirring syringe filled with ligand solution injects
the titrant in steps of several µL into the sample cell under constant stirring. As interaction in
the sample cell can cause either an exothermic or endothermic signature, the feedback circuit will
adjust heating of the sample cell in order to maintain the reference temperature. The temperature
difference resulting from such injection is then measured as difference to the reference cell by
thermocouples. The direct observable signal of the ITC is the heat flow per unit of time dQ/dt.
and protein solution (see Figure 4.2 bottom).
Sample preparation and experiments were conducted as follows:
Stock solutions of 10 mM MOPS 1 buffer were prepared with pH 7.2 and according amounts
of NaCl added to adjust ionic strength of the solution. These buffer solutions were used to
prepare both protein and ligand solution and were also used for dilution experiments. For
the polyacrylic acid (PAA), stock solutions of PAA were dialyzed for several days against
buffer solution to match pH2. HSA was equally dialyzed and the concentration measured
afterwards using UV-vis (see Appendix Figure 8.2). The dialysis-system used was the
Float-a-Lyzer by Spectrum Labs with molecular weight cut-off (MWCO) of 500− 1000 Da
1MOPS: 3-(N-morpholino)propanesulfonic acid
2This procedure was used to avoid the necessity of adding too much salt and thus change the
ionic strength of the ligand solution.
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Figure 4.2: Raw ITC data on the example of IDS
adsorption to HSA. Top panel shows titration peaks
measured as heat flow over time dQ/dt in µcal/mol.
Two injection volumes 3 µL and 6 µL are used in the
present case to increase resolution at the critical part
of the reaction. Blue lines are dilution measurements
conducted by titrating IDS into according plain
buffer solution. Bottom panel shows the integrated
incremental enthalpy ∆Q divided by the moles of
injected ligand where black symbols are adsorption
and blue symbols dilution heats.
for PAA and MWCO 20 kDa for HSA, respectively. For the uremic toxins, minor amounts
of NaOH was added to adjust the pH of the ligand solution to 7.2.
Prior to experiments, all samples were degassed for 10 min at the experimental temperature
using the ThermoVac degassing and thermostatting station.3 Samples were then thermostat-
ted and the instrument stabilized for 1 h to ensure thermal equilibrium and stability of the
system. Finally, a total of 298 µL ligand solution was titrated, using either two different
injection volumes of 20 successive 3 µL followed by 36 successive 6 µL titrations for the
uremic toxins or 70 successive 4 µL injections for the polyelectrolyte. The equilibration
time interval between each injection was between 280− 350 s depending on the system.
For each set of condition, e.g. for a certain temperature and ionic strength, dilution of
the ligands/polyelectrolyte were obtained by measuring the titrant heat when injected to
pure buffer solution without protein. This heat of dilution was then subtracted from the
according heat of adsorption. An example of such an experiment for IDS adsorption to HSA
is shown in Figure 4.2, where black lines and symbols represent the adsorption and blue
the dilution experiment. After correction, the resulting binding isotherm is fitted using the
ITC module of the Origin® 7.0 software supplied by Microcal. [126] The fitting algorithm is
described below and the models applied for analysis are described in detail in Section 4.1.
An overview of the experiments performed at the VP-ITC is shown in Table 4.1.
4.1.1 Challenges and pitfalls of ITC
In an ITC measurement, the shape and quality of the isotherms are influenced by the choice
of experimental conditions and especially sensitive to absolute concentrations of protein
3This step is important, as bubbles during the titration can distort the measurement.
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Table 4.1: Overview of ITC experiments. Ionic strengths were adjusted by adding according
amounts of NaCl to 10 mM MOPS buffer solution at pH 7.2.
System Ionic strength Temperature c(HSA) c(ligand)
in mM in K in mM in mM
PAA + HSA∗
20; 50 298; 300.5; 303; 306; 310 0.02 0.5
70; 100 310 0.02 0.5
PhAA + HSA
∗ 20; 150 298; 303; 310 5.88 0.015
50; 70; 100; 310 5.88 0.015
PhAA + HSA-Urea 20; 150 298; 303; 310 5.88 0.015
IDS + HSA∗ 20; 150 298; 303; 310 1.99 0.015
IDS + HSA-Urea 20; 150 298; 303; 310 1.99 0.015
∗ HSA without further specification relates to native HSA while HSA-Urea relates to urea
modified HSA as specified in Section 8.1 of the Appendix.
and ligand. The optimal concentrations depend on the mechanisms of binding and the
binding affinities Kb. A quantitative way to approximate the shape is given by the following
equation:
c = NKb[P ]tot (4.1)
where N is the number of ligands bound to protein, Kb the binding affinity and [P ]tot
the total concentration of protein in the cell. Figure 4.3 demonstrates different shapes of
isotherms depending on the choice of concentrations and thus the effect of the parameter
c. [137] As the simulated curves demonstrate, both too large or too small values for c
Figure 4.3: The shape of simulated ITC curves with varying parameter c. Adapted from [137].
will lead to increased errors in ∆HITC and Kb in the fitting procedure. ∆HITC is well
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defined if a plateau is measured, as in cases of c < 50. Furthermore, an accurate fitting
of the binding constant Kb requires c < 500, because only then enough data points are
measured to describe the curvature of the inflection point. Thus, an ideal ITC experiment
is carried out using concentrations matching c values between 50 and 500. However, some
systems cannot fulfill this requirement, as is the case with PAA. As will be shown in the
following, the dilution heat of PAA is exceptionally large, such that experiments can only
be performed at low concentrations. As a consequence, concentrations for HSA are equally
low to reach an equilibrium at the end state of the experiments.
The heat of dilution of the ligand into buffer solution can in some cases deviate from the
simple case, where it shows only a small and constant heat contribution independent of
molar ratio. For a more complex case, the heat of dilution ∆Hdil depends on an activity
coefficient of the i-th solute γi: [138]
∆Hdil =
∑
i
υiRT lnγi
(
1 + T∂
∂T
)
(4.2)
where υi is the stoichiometric coefficient and  the permittivity. For dilution of PAA, the
amount of heat generated after each injection is non-constant, as the activity coefficient for
already dissolved ions changes with each titration of ligand. Moreover, water-related effects
such as solvation and reorganization of water upon PAA dilution can lead to varying of
∆Hdil with molar ratio. A typical measurement of PAA titration in plain buffer solution at
Figure 4.4: Raw ITC data of PAA titra-
tion into buffer solution at 30 ◦C and
I = 50 mM.
30 ◦C and I = 50 mM is shown in Figure 4.4. The heat of dilution for PAA was measured
at all conditions separately and subtracted from the heat of adsorption to obtain reasonable
isotherms of binding.
However, the concentrations of the protein and PAA are small and the evolved heat will be
concomitantly small. Hence, all effects leading to spurious heat signals must be considered
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in detail and carefully excluded. The main problem is the adjustment of the same pH
and ionic strength in both the solution of the protein and of the polyelectrolyte. This is
done by extensive dialysis which turned out to be decisive for obtaining meaningful ITC-data.
A further aspect that can influence the measured isotherm, are structural changes of the
protein induced by ligand binding. Unfolding or reorientation of the secondary structure of
a protein will be accompanied by an enthalpy change and falsify derived binding affinities.
Furthermore, the stability of the protein and the complex formed are important prerequisites
to fulfill the thermodynamic equilibrium condition. Aggregation and dimerization of proteins
under e.g. certain pH or high ionic strength will give an extra ∆HITC and thus influence
the fitting of Kb.
4.2 Small-angle neutron scattering (SANS)
This chapter resumes the basics of neutron scattering experiments and fundamental concepts
required to follow the interpretation of the performed experiments. The used instruments
are briefly presented through the example of the SANS instrument V16 [139], located at
the BER-II facility at Helmholtz-Zentrum Berlin (HZB), Germany and the D11 located
at the Institut Laue-Langevin (ILL) in Grenoble, France. [140] For detailed information
on instruments and experimental details, the reader is referred to the homepage of the
institutes. [141–143]
Neutrons are uncharged spin-1/2 particles with a magnetic moment of µ = −1.923 nuclear
magnetons. As such, they interact directly with the atomic nucleus (via the strong nuclear
force) and via a magnetic moment. The range of the nuclear force is orders of magnitude
smaller than the neutron wavelength and therefore the scattered wave is isotropic with its
amplitude being proportional to the so-called scattering length b. The value of b does not
only depend on the element but also on its isotope and the spin-state of the neutron-nucleus
system. In the absence of a theory for nuclear forces b is an experimentally determined
quantity. Depending on their energy, neutrons can be classified as hot, thermal or cold.
Their average energy corresponds to about kBT with temperatures between 6000 K − 1 K,
respectively. Neutrons can be described either classically as particles with a mass of
m = 1.675 · 10−27 kg or via the de Broglie equation with a wavelength λ of:
λ = 2pi|k| =
h
m|v| (4.3)
and a wavevector |k|, a velocity |v| and the Planck constant h. The energy E of a free
neutron is:
E = 12mv
2 = }ω = hv (4.4)
= }
2k2
2m =
h2
2mλ2 (4.5)
Neutrons used for structural investigations by SANS usually have a wavelength in the range
3− 10 Å, corresponding to the magnitude of the particle of interest. Thus, they belong to
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the class of cold neutron. Some of the biologically relevant elements and their according
scattering lengths of both neutrons and X-rays are listed in Table 4.2 for comparison.
Table 4.2: Scattering lengths and cross sections for X-ray and cold neutrons of biologically relevant
elements. [129, 144]
Atomic bcoh σcoh σinc bX-ray
Elements number in 10−12 cm in 10−12 cm in 10−24 cm2 in 10−12 cm2
1H 1 −0.374 1.76 79.9 0.38
1D (2H) 1 0.667 5.59 2.04 0.38
C 6 0.665 5.55 <0.01 0.168
N 7 0.936 11.01 0.49 0.197
O 8 0.580 4.23 <0.01 0.225
P 15 0.513 3.31 <0.01 0.423
S 16 0.285 1.02 <0.01 0.450
Neutrons: bcoh coherent scattering length
σcoh, σinc coherent and incoherent scattering cross section
X-Rays: bX-ray scattering length for small angles
4.2.1 SANS instruments
Neutron experiments were performed at the SANS instruments V16 and V4 of the Helmholtz-
Zentrum Berlin’s BER-II reactor in Berlin, Germany [139, 143, 145], at the KWS-II of the
FRM-II reactor at the Maier-Leibnitz Zentrum (MLZ), Garching, Germany [141] and at the
D11 of the Institut Laue-Langevin in Grenoble, France [142]. While the details of each instru-
ment can be found at the according websites of the institutes, the following chapter intents to
briefly summarize the basic principles and also differences between a time-of-flight (TOF) in-
strument and a monochromatic instrument. Thereby, the main focus will be to elucidate the
general instrument design of the V16, as the principles underlying all instruments are similar.
The V16 employs the TOF method to take advantage of a broad spectrum of neutrons. [139]
In contrast to monochromatic instruments that use velocity selectors, a combination of
choppers is used at the V16 to tune the width and range of the continuous neutron flow
from the reactor. A scheme of the instrument V16 is shown in Figure 4.5, where the neu-
tron beam first reaches the four choppers with flexible rotation frequencies and maximum
speed of 3000 rpm. The chopper configuration can be adjusted to the individual needs of
an experiment in terms of wavelength band of the neutrons. In experiments, where the
q-resolution plays a minor role, a setup with a broad neutron band, high flux but lower
resolution ∆q/q between 5 % − 18 % can be chosen.
After the last chopper, a low efficiency detector, the monitor, is installed to detect the
count rate of incoming neutrons for data normalization. Afterwards, the neutrons pass a
standard collimation system with adjustable distances up to 12 m. Before reaching the
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Figure 4.5: Schematic depiction of the instrumental set-up of V16. Adapted from [143].
sample, the neutrons pass an aperture of 40× 40 mm to reduce divergence of the beam and
to increase q accuracy. After being scattered by the sample, the neutrons pass an evacuated
detector chamber with a 2D 3He detector with an area of 100× 100 cm2. The detector can
be moved along the beam direction to achieve sample-to-detector distances of 1.7 − 12 m
and thus covering different spatial angles. A combined choice of detector distance and
wavelengths between 2.5 Å ≤ λ ≤ 18 Å gives access to a q range between 0.002 Å−1−0.8 Å−1.
A monochromatic instrument follows very much the same layout as the TOF instrument
described above. However, these instruments only uses one wavelength with a certain
distribution ∆λ/λ depending on the instrument. The neutrons are mono-chromatized by a
velocity selector, which consists of a rotating drum with helically curved absorbing slits at
its surface. The desired wavelength or equivalently the velocity of neutrons is determined
by choosing the appropriate rotation speed similar to the working principle of choppers.
An overview of instrumental settings for experiments performed at different beamlines is
listed in Table 4.3.
4.2.2 Primary data reduction
The 2D signal measured by the detector has to be corrected in many steps and averaged
over the whole azimutal angle to obtain a normalized differential cross section usable for
data analysis (see Section 3.3.1). A detailed description of the extensive data reduction can
be found in [146, 147]. However, a rough overview of the reduction steps are presented in
the following as key points:
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Table 4.3: Overview of experimental setups for all experiments performed at different instruments.
Detector Collimation Frequency in rpm (φ in ◦) λ1 ± 10 % λ2 ± 10 %
distance in m in m Chopper 1 Chopper 3 Chopper 4 in Å in Å
Instrument V16 @ HZB, Berlin
1.7 6 3000 (0) 3000 (−5) 3000 (−90) 1.8 3.2
12 12 770 (0) 770 (−3) 770 (−50) 2.8 8
Instrument V4 @ HZB, Berlin Selector frequency in rpm λ± 10 % in Å
1 2 21000 4.5
1 2
28300 6
8 4
Instrument KWS-II @ MLZ, Garching λ± 10 % in Å
1.12 8
- - - - 5.27
3.73 8
5.73 8
19.73 20
Instrument D11@ ILL, Grenoble Selector frequency in rpm λ± 10 % in Å
1.2 4
28070 4.6
8 8
1.2 4
12910 10
8 8
V16: Chopper 2 was not used for all experiments, φ denotes the phase shifts
KWS2: The selector velocity is unknown
1. Determination of the beam center.
2. Creation of a detector mask to avoid beam-stop effects or border effects of the
detector.
3. Normalization for incoming flux measured by the monitor.
4. Transmission correction.
5. Subtraction of not experimental related signals (e.g. electronic noice, background
radiation). For this, scattering and transmission are measured using an absorber
material for neutrons like boron carbide (B4C).
6. Subtraction of scattering form the sample vessel (usually quartz cuvette).
7. Radial averaging.
8. Normalization to absolute intensity. Taking advantage of the fact that water scatters
predominantly incoherently and thus uniformly over the whole q-range, it is used as
reference measurement.
9. Rebinning to constant q-spacing according to specific requirements of the data.
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Finally, the absolute scattering cross section independent of instrumental and experimental
set-up d
∑
dΩ = I(cm−1) is obtained. These reduction steps are carried out using the free
software MANTID [148] with an internally developed algorithm. [139]
4.3 Simulation methods
Computer simulations were performed by X. Xu from the group of Prof. Dr. J. Dzubiella.
The following chapter shall give a brief overview of the conditions of the simulation and
according parameters used. Details can be found in [149].
4.3.1 Computer simulation model and parameters
To model the interaction between polyacrylic acid and HSA, Langevin dynamics simulations
were employed using an implicit-water coarse-grained (CG) model. [150] Similar methods
have been used repeatedly to study e.g. protein folding [151] and the pair potential [152]
between proteins. Each amino acid of the protein, PAA monomer, and salt ions is explicitly
represented by a single interaction bead, while the water is implicitly modeled by a dielectric
background continuum.
The protein sequence for the HSA is provided by PDB database 4. [153] The native structure
of the protein is maintained by a Go-model like force field. [154, 155] All beads corresponding
to basic and acidic amino acids are assigned with a positive or negative charge, depending
on their dissociation state at physiological pH = 7.4, resulting in a net charge of HSA of
−1e. The short polyelectrolyte chain is modeled as a flexible sequence of Nmon = 25 freely
jointed beads with a radius σLJ and an electric charge of −1e. The PAA monomers are
connected by a harmonic bond potential and the flexibility of the PAA chain is defined via
a harmonic angle potential. The dynamics of the beads is governed by Langevin’s equation
of motion. [156] Coulomb interactions govern the electrostatic pair potential between all
charged beads.
One HSA and several PAA chains are simulated in a cubic box with side lengths of
L = 30 nm and periodically replicated walls to generate a quasi-infinite system in the
canonical ensemble. For the continuous water background, a static dielectric constant is set
to r = 73.4 and 78.2 for temperatures T = 25 ◦C and 37 ◦C, respectively. Molar ratios
x = cPAA/cHSA ranging from 1 to 10 were simulated to elucidate the effect increasing PAA
chains in the solution. Salt concentration csalt range from 20 to 100 mM to compare with
experimental conditions.
4.3.2 Binding and free energy calculations
The stoichiometry that is the average number of bound PAA chains on one HSA, can be
determined through a calculation of the normalized density distribution function g(r) =
4PDB ID=1N5U
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c(r)/cPAA, where r is the distance between the centers-of-mass (COM) coordinates of the
HSA and PAA and cPAA is the PAA bulk concentration. Integration of g(r) leads to the
PAA coordination number
n(r) = 4picPAA
∫ r
0
g(r′)r′2dr′. (4.6)
which describes how many PAA chains are bound on average at a distance r. To quantify
the number of bound and released ions upon complexation, the average number of ions Ni,
i = ±1 bound (condensed) to the PAA chain or to the positive protein patches, is count
respectively. An ion is defined as ’condensed’ if it is located in the first binding layer, with
a cut-off distance rs = 0.5 nm from the charged bead, thus double-counting in overlapping
volumes is avoided. The number of released ions is obtained by a comparison before and
after PAA/HSA association.
The potential mean force (PMF) between HSA and PAA was calculated using steered
Langevin Dynamics simulations. [150] Here, the center of mass of the PAA is restrained
in space by an external time-dependent force. This force is applied as a constraint, i.e.
harmonic potential, and moved with a constant pulling velocity vp to steer the particle
in the prescribed direction (see Figure 4.6). [157] The binding affinity of the PAA can be
defined as the free energy value at the global minimum of the PMF in the stable complex.
Figure 4.6: Simulation snapshot of a pulling experiment with velocity vp. The amino acid beads
of HSA is illustrated as a transparent surface plot where neutral beads are colored white, positive
and negative beads are green and red, respectively. PAA is represented as a yellow string of
beads.
However, before making a comparison with the experiment, it has to be taken into consider-
ation that ∆Gexpb provided by the experiment is defined as a standard free energy, which
refers to the standard binding volume V0 = 1/C0 of one liter per mol. [158] Hence, the
standard binding free energy from the simulation can be obtained as:
∆Gsimb = ∆Gcorr + ∆Gsim, (4.7)
with a term ∆Gcorr = −kBT ln(C0Vb) that is the entropy correction arising from the
accessible volume of the COM of the PAA in the bound state.
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The first part of this thesis presents the interaction between the model polyelectrolyte
polyacrylic acid (PAA) and HSA from a thermodynamic and structural point of view. The
binding is analyzed experimentally by varying ionic strength and temperature as crucial
parameters that influence the interaction. The results obtained by ITC are then compared
to computer simulations of the same system. In a second part, spatial studies on the
PAA-HSA complex are conducted by detailed characterization of the pure protein solution
to observe possible structural changes upon complexation.
5.1 Thermodynamic analysis of binding
A systematic series of ITC experiments was performed, comprising four ionic strengths
and five different temperatures ranging from room temperature (25◦C) to the physiological
temperature (37◦C) in buffer solution of pH 7.2. All experiments were performed with PAA
solution as injectant that was titrated into the protein solution in the cell.
Figure 5.1 displays the raw ITC-signals of PAA onto HSA (black lines and points) as well
as the heat of dilution of PAA (blue lines and symbols). The signal is weakly endothermic
at I = 20 mM but exothermic at I = 50 mM (see Figure 5.1a) and b). Dilutions are
in all cases exothermic and the effect becomes stronger with increasing salt content as
expected (blue curves and points). For higher ionic strength, the heat of dilution has a
dominant effect on the overall signal and determines the sign of the signal at I > 20 mM.
For data analysis, the heats of dilution are subtracted from the heats of adsorption prior to
fitting. Attention must be paid to this step, as for some cases a constant residue remains
after subtraction of the heat of dilution. Even though this offset signal is very small and
usually less than 0.1 kcal/mol, it cannot be neglected due to the small overall heat. This
offset can be assigned to a slight mismatch of the pH or salt between the titrant and the
solution in the cell. In order to take this effect into account, a flat background was fitted to
all isotherms after the first step of subtraction and used to correct the data in the second step.
The panel on the right-hand side of Figure 5.1 displays a set of typical results obtained. Ev-
idently, the heat of adsorption is positive and is found for all conditions under consideration
here. Hence, the driving force for the process of adsorption must be entropic. This point
will be discussed in more detail below and is well borne out from the simulations, too.
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Figure 5.1: ITC data of binding of PAA to HSA at pH = 7.2, T = 37 ◦C and a) I = 20 mM, b)
I = 50 mM. Top panels show raw titration peaks of adsorption (black lines and points) and
dilution (blue lines and symbols) of PAA and bottom panels show corresponding integrated
heats as a function of molar ratio n(PAA)/n(HSA). c) Binding isotherm corrected for the heat
of dilution at 37◦C and I = 20 mM (green circles) & 50 mM (blue triangles) with corresponding
fits (black line). Reprinted with permission from [149]. Copyright 2015 RSC Soft Matter.
In order to obtain the number N of PAA-molecules bound to one HSA-molecule, the data
were first fitted using the SSIS model as described in Section 3.2.1 and the algorithm
described in Section 4.1. The binding number N , binding affinity Kb and the overall
enthalpy change measured ∆HITC can be obtained by fitting the isotherm. Figure 5.2
shows a comparison of the parameter N for the two data sets as in Figure 5.1. The colored
curves showing different fixed values of N reveal that the data clearly justify N = 1 as the
best choice for fitting. This observation is true for any other data sets. Deviations from
N = 1 are not significant and N = 1 can safely be assumed in all subsequent analysis. This
leaves only Kb and ∆HITC as free fit parameters and thus giving reliable results for both
parameters.
5.1.1 Strength of interaction as a function of temperature
Figure 5.3a) and (b) each presents a series of measurements conducted at two ionic strengths
I = 20 mM and 50 mM to study the dependence of binding on temperature. For better
clarity, only three temperatures are displayed in these graphs. The data for two more
temperatures are displayed in Figure 5.3c) and (d). The data taken at both ionic strength
reveal a significant increase of enthalpy with increasing temperature from 25◦C to 37◦C.
This effect is more pronounced for I = 20 mM than at I = 50 mM.
Additionally, the overall enthalpy of adsorption becomes weaker with increasing salt content,
which points directly to the importance of electrostatic interaction on the binding of PAA
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Figure 5.2: Determination of the parameter N , i.e., the number of PAA molecules adsorbed on
HSA molecule is shown for one temperature 37◦C at a) I = 20 mM and b) 50 mM. Each line
shows a fit with different values of fixed N marked by different colors. Reprinted with permission
from [149]. Copyright 2015 RSC Soft Matter.
onto HSA. All data are very well described by the model assuming N = 1. Data taken
at higher salinity are more noisy but the raise of the signal with temperature is clearly
discernible. Since there is no plateau in the ITC signal, the parameter ∆HITC might be
overestimated by the fits.
The results of these fits are listed in Table 5.1 with ∆HITC and Kb as fit parameters, N
being fixed to unity (see above). The free energy of binding ∆Gb was calculated from the
fit parameter Kb using Equation (3.20).
The strength of binding as a function of temperature can now be analyzed according to
van’t Hoff’s law (see Equation (3.26) in Section 3.2.3). Figure 5.4 shows the resulting van’t
Hoff plot. A linear correlation between logarithm of the binding constant Kb and the inverse
temperature is seen within the limits of errors. The binding enthalpy ∆Hb can be obtained
from the slope of the linear fit and ∆Sb from the intercept. The resulting data are gathered
in Table 5.1. In general, the values of ∆HITC are larger than the data resulting from the
van’t Hoff analysis. Similar findings have been made in a recent study of the interaction
of proteins with charged microgels. [159] Reasons may be sought in additional processes
as e.g. the hydration of freed counterions that are not directly coupled to the process of
binding (see below). Also, the heat of adsorption taken directly from the ITC data might
be slightly overestimated (see above).
In literature, the distinction is usually made between an “observed” or “apparent” enthalpy
measured by the ITC, defined as ∆HITC in the present thesis and the van’t Hoff enthalpy
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Figure 5.3: Effect of temperature. The integrated heats Q for adsorption of PAA on HSA at
temperatures of 25°C, 30°C and 37°C and the corresponding fits are displayed at the top panels
for (a) I = 20 mM and (b) I = 50 mM. For better clarity, isotherms at 27.5°C and 33°C are
displayed separately in the bottom panel for (c) I = 20 mM and (d) I = 50 mM. Reprinted with
permission from [149]. Copyright 2015 RSC Soft Matter.
∆Hb determined by the temperature variation of Kb as described above. [160–162] The
frequently observed difference between both enthalpies cannot only be attributed to a lack
of experimental precision as in some distinct cases [163, 164], but may persists beside proper
error propagation. This finding is demonstrated on a standard ITC test reaction, namely
the complexation of Ba2+ with 18-crown-6 ether. [161] In a study on this system, Mizoue
and coworkers evaluated different assumptions of error and concluded that the discrepancy
between ∆HITC and ∆Hb are statistically significant. [161] Other authors likewise believe
that additional effects, not directly associated with binding, contribute to ∆HITC , such as
buffer ionization and protonation effects of proteins. [124, 159] Furthermore, the linkage of
buffer interactions with binding can result in nonconventional and nonlinear ∆Hb profiles,
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Figure 5.4: Van’t Hoff analysis of the
dependence of the adsorption con-
stant on temperature. Data points
are derived from the fits of the ITC-
data shown in Figure 5.3a) and b).
The crosses correspond to I = 20 mM
and the open squares to I = 50 mM.
thus complicating data analysis. [124, 164] The proton transfer reaction can be written as
follows: [165]
∆HITC = ∆Hb + nH+∆Hion (5.1)
where ∆Hion is the heat of ionization of the buffer and nH+ either the number of protons
taken up (nH+ < 0) or released (nH+ > 0). This enthalpy becomes apparent, when the same
two interaction partners are placed in different buffer solutions. [159] The effect of ionization
and more specifically protonation is moreover experimentally observed by Niedzwiecka et
al. as a constant discrepancy between ITC enthalpy and van’t Hoff enthalpy. [166] Further
unspecific heat contributions such as conformational changes, can additionally add to the
heat measured by ITC, hence it is reasonable to define a residual heat ∆Hres, which links
∆HITC and ∆Hb: [56]
∆HITC = ∆Hb + ∆Hres (5.2)
An alternative to the simple approach of assuming ∆Cp = 0 is to fit ∆Cp and lnKb
using Equation (3.24) and then take this value into account when estimating a temperature
dependent ∆H0vH as given by Equation (3.25). The data shown in Figure 5.3 are thus
reevaluated and a representative fit is shown exemplarily for each ionic strength at one
temperature (298 K) in Figure 5.5a). After obtaining the new van’t Hoff enthalpies ∆H0vH
at each reference temperature T0, the values are compared to measured enthalpies ∆HITC
as depicted in Figure 5.5b).
The recalculated van’t Hoff enthalpies ∆H0vH are in accordance with ∆HITC within the
limits of error for low temperatures (see Figure 5.5b). The difference ∆Hres of recalcu-
lated enthalpies at 298 K, for instance, have decreased to ≈ −6 kJ/mol, compared to
≈ −30 kJ/mol for the standart van’t Hoff analysis. For increasing temperature, the uncer-
tainties are rather large and more experiments in smaller temperature steps are necessary
to obtain a more reliable fit than shown in Figure 5.5a). For the low ionic strength how-
ever, the discrepancies between fit and data lnKb are too large and yield non-physical results.
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Figure 5.5: Reevaluated van’t Hoff analysis assuming nonzero ∆cP . (a) The new fit (solid line)
uses Equation (3.24) to reevaluate the data from Figure 5.4 with T0 = 25◦C as reference
temperature (fits with other reference temperatures do not deviate significantly from the shown
one). The linear van’t Hoff fit from Figure 5.4 is shown for comparison as dashed lines. (b)
According van’t Hoff enthalpies were calculated for each temperature as T0 using Equation (3.25)
(open symbols) and compared to measured enthalpies ∆HITC . The dotted line marks the
enthalpy calculated by the simple van’t Hoff Equation (3.26).
5.1.2 Dependence on ionic strength
To study the dependence of the binding process on ionic strength, two more experiments at
37◦C and I = 70 mM and 100 mM were conducted (raw data are shown in Figure 8.8 in
the Section 8.3 of the Appendix). With increasing ionic strength, the measured enthalpy
approaches zero and the ITC method reaches its instrumental limits. As described above,
the parameter N was fixed for both salt concentrations to unity. Table 5.1 gathers all data
obtained from these experiments.
The data exhibit a very consistent decrease of binding constant Kb with increasing salt
concentration (see Table 5.1). This observation combined with the fact that only about one
PAA molecule is adsorbed on the HSA leads to the conclusion that the driving force of the
interaction is an attractive electrostatic potential between the negative PAA with patches
of positive charge on the surface of HSA molecule. As discussed in Section 3.1.3, these
patches are known to act as multivalent counterions for the polyelectrolyte and binding
between PAA and such a patch thus leads to a release of its counterions. [54, 115, 159] A
linear relationship between the logarithms of binding constant and salt concentration was
considered many years ago by Record and Lohman (see Equation (3.28)). [117] This behavior
is observed for the present data as well if the ionic strengths is above 20 mM (see Figure 5.6).
Application of Equation (3.28) to the data in Figure 5.6 yields ∆nion ≈ 2.9± 0.5, that is,
approximately 3 ions are released upon binding of one PAA-molecule to a HSA molecule.
The deviation from linearity for low ionic strength has been observed as well by Dubin et
al. for the interaction between Bovine Serum Albumin and the polyanion Heparin at pH
6.8. [55] Here, electrostatic interactions become long-ranged and the relative contributions
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Figure 5.6: Effect of ionic strength. (a) Isotherms are shown for a series of ionic strengths ranging
from I= 20 − 100 mM at 37°C. All fits have been done with N = 1. (b) Linear dependence
of the binding constant versus ionic strength as listed in Table 5.1 are depicted in logarithmic
scales according to Equation (3.28). [117] Reprinted with permission from [149]. Copyright 2015
RSC Soft Matter.
of the counterion release mechanism significantly decrease.
Extrapolation of the linear fit reveals that interaction still persists at physiological ionic
strengths and temperature. At I = 150 mM and 37◦C, a finite binding free energy of
around -17 kJ/mol can be derived from the plot and it only decays to small values at
around 750 mM. This concentration has been found to be necessary in dialysis to remove
protein-bound uremic retention solutes. [30] Evidently, there is still some binding under
physiological conditions and much higher salt concentrations are needed to remove the
toxins from the surface of HSA. These results show also that ITC-experiments can be
deceptive when enthalpies of different reaction in the system compensate in such a way that
they vanish. Thus, in the present case interaction still exists under physiological conditions
but does not lead to measurable enthalpies.
5.1.3 Comparison to theoretical modeling of binding
Implicit-water, coarse-grained (CG) and structure-based computer simulation are presented
in the following to gain additional insight, such as kinetic information on the binding
between polyelectrolyte and protein that can not be obtained by ITC alone. This type
of simulation provides a full microscopic picture of the interaction of PAA with HSA, in
particular the identification of the sites where PAA docks on. Moreover, the simulations
can be used to obtain realistic free enthalpies of binding as will be further shown below.
The computer simulations demonstrate that HSA binds only one PAA chain, independent
of temperature, salt concentration, and molar ratio in the considered parameter ranges.
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Table 5.1: Overview of thermodynamic parameters for all fitted isotherms for the temperature
series between 25◦C-37◦C and ionic strengths between I = 20 mM - 100 mM. As discussed
in Section 3.2.1, all data were fitted with fixed N = 1. ∆Gexpb , ∆Sb and ∆Hb were calculated
according to Equation (3.20) and Equation (3.26) respectively. Entropy for 70 mM and 100 mM
were calculated using Equation (3.21) at 37◦C.
Ionic strength T ∆HITC Kb · 104 ∆Gexpb ∆Sb ∆Hb
in mM in ◦C in kJ/mol in mol−1 in kJ/mol in kJ/mol/K in kJ/mol
25 16.4±0.3 7.7±0.5 -27.9±1.3
27.5 32.8±0.6 5.8±0.3 -27.4±1.4
20 30 34.0±0.5 6.9±0.3 -28.1±1.1 0.17±0.01 15±4
33 45.6±0.9 8.1±0.5 -28.8±1.6
37 53.4±1.0 8.3±0.5 -29.2±1.5
25 13.6±1.1 1.3±0.2 −23.4± 0.5
27.5 14.4±0.9 1.6±0.2 −24.2± 0.3
50 30 24.8±0.7 1.7±0.1 −24.6± 0.1 0.27±0.02 44±8
33 27.6±0.9 1.8±0.2 −24.9± 0.2
37 26.4±0.6 2.6±0.1 −26.2± 0.1
70 37 21.9±0.7 1.0±0.1 −23.6± 0.5 0.12 (37◦C)
100 37 8.5±2.8 0.3±0.1 −20.7± 1.2 0.10 (37◦C)
Hence, it reconfirms the result obtained previously by ITC. A representative simulation
snapshot of the bound complex with one PAA is presented in Figure 5.7. From a thor-
ough screening of the simulation trajectories, it emerges that this is a highly reproducible
and stable configuration which is assumed in 80 % of the simulation time. Figure 5.7b)
reveals that the PAA chain spans the sub-domains II A, III A, and III B, involving the
Sudlow II binding site. As expected for a negatively charged polyelectrolyte, it favorably
binds to positively charged amino acids (highlighted as green opaque spheres in Figure 5.7b).
It is furthermore interesting to see the temporal evolution of the complex of HSA with PAA.
The PAA chain slides along the Sudlow II site much in a way of a threading through an
orifice. On the one hand, this fact demonstrates the strong binding of PAA by this side.
On the other hand, the threading through this site leads to a strongly increased number
of configurations of the complex and thus increases the entropy of the complex. This fact
certainly leads to the binding of the PAA-chain at the Sudlow II site and not on other
positive patches on the surface of HSA.
A further aspect that can be compared to experimental results is the binding free energy
that can be determined through the free energy profiles (potential of a mean force) (see Sec-
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Figure 5.7: (a) Representative computer simulation snapshot of the total HSA-PAA complex. (b)
Magnification of the binding site: the PAA (yellow string of beads) is bound near the Sudlow II
site. The amino acid beads that directly participate in the binding (defined by being within
0.5 nm distance to the PAA on average) are depicted by the opaque spheres. The rest of the
HSA structure is distinguished by a transparent surface plot. Electrostatically neutral HSA
beads are colored white, positive beads are green, and negative beads are red. Reprinted with
permission from [149]. Copyright 2015 RSC Soft Matter.
Figure 5.8: A series of snapshots depict the binding process.Reprinted with permission from [149].
Copyright 2015 RSC Soft Matter.
tion 4.3.2). Examples for this interaction free energy G(r) between a single uncomplexed
HSA and one PAA at two salt concentrations is presented in Figure 5.9 along the HSA-PAA
distance coordinate. At about r ' 6 nm the onset of a strong attraction takes place until
a global minimum is observed at closer approach at about r = 2 nm. Adsorption of a
second PAA chain onto HSA is never observed in the simulations. This is due to a too
strong monopole charge repulsion and the covering of the high-potential binding spot by the
firstly bound PAA. The binding free energy ∆Gsim can be calculated from the difference
of the global minimum and the reference free energy at large distances (horizontal lines
in Figure 5.9).
The values of the simulation binding free energy, corrected to yield the standard free energy
of binding from the simulations ∆Gsimb (see Section 4.3.2), are summarized in Table 5.2 for
various salt concentrations and temperatures. Good agreement is found for all systems and
the same influence of salt and temperature are observed by simulations as by experiments.
However, it is somewhat surprising that the highly quantitative description by simulations
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Figure 5.9: Free energy profile (or potential of mean force) G(r) between the PAA and the HSA
versus their centers-of-mass distance r at a temperature of 25 ◦C and for 20 mM (red) and
50 mM (blue) salt concentrations. The binding free energy ∆Gsim derived from the simulation
can be read off as the difference between the zero free energy reference state at far separation
(horizontal black dotted line) and the global minimum representing the bound state (horizontal
blue and red dotted lines). Reprinted with permission from [149]. Copyright 2015 RSC Soft
Matter.
Table 5.2: The calculated standard binding free energy from the simulations ∆Gsimb in comparison
with the experimental ones ∆Gexpb for various salt concentrations and temperatures in units of
kJ/mol. ∆Gsim is the direct output from the simulations which has to be corrected by ∆Gcorr
for the binding volume Vb to obtain the standard free energy of binding.
Conditions ∆Gsim Vb ∆Gcorr ∆Gsimb ∆G
exp
b
(kJ/mol) (nm3) (kJ/mol) (kJ/mol) (kJ/mol)
20 mM, 25 ◦C −24.8± 4.0 3.0 −1.5 −26.3± 0.5 −27.9± 0.2
20 mM, 37 ◦C −25.1± 3.6 5.9 −3.1 −28.2± 3.6 −29.2± 0.2
50 mM, 25 ◦C −16.1± 1.0 16.0 −5.7 −21.8± 1.0 −23.5± 0.5
50 mM, 37 ◦C −18.9± 0.5 7.5 −3.9 −22.8± 1.5 −26.2± 0.2
coincide so well with experiments, given the simplicity of the underlying model and the
neglect of hydration effects. While the results should be discussed with caution, they can
be taken as a strong indication that relatively generic electrostatic interactions rule the
complexation process and hydration contributions (such as hydrophobic or van der Waals
(vdW) attractions) are rather small.
In order to access the contributions of the counterion release force as suggested by the
experimental results, the number of released ions upon complexation is counted (Plot
showing the number of ions versus distance is given in Figure 8.9 of the Appendix). An
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ion is defined as condensed, if it is located in the first bound layer near a charged HSA
or PAA monomer, with a cut-off radius of 0.5 nm (density profiles of positive salt ions
around the PAA monomers are shown in Figure 8.10 of the Appendix). For a temperature
of 25 ◦C and 20 mM and 50 mM salt concentrations, an average of 2.5 condensed ions are
diluted away into the bulk upon complexation. This is indeed in good agreement with the
Record-Lohman-analysis of the experiment data discussed above.
Deeper inspection shows that two of those ions come from the PAA, which leads to an
average concentration in the bound state of cdense ' 1.5± 0.5 mol/l. This implies that a
favorable entropy contributions of about ' kBT ln(cdense/cs) = 4.3± 0.4 and 3.4± 0.4 kBT
is gained per ion upon its release into 20 mM and 50 mM bulk concentrations, respectively.
The total released free energies estimated by this analysis are thus roughly −21± 2 and
−17± 2 kJ/mol for 20 mM and 50 mM salt, respectively, which is close to the binding free
energies from both experimental data and simulations.
Hence, the binding of PAA is to a great part ruled by a counterion release mechanism
and entropy. However, the matching of these numbers may be fortunate since other non-
negligible interactions such as (repulsive) chain entropy, vdW attractions, and multipolar
charge interactions beyond the bound ion layer (that is from screening ions), all present
in both simulation and experiment, have been neglected in this simple counterion release
concept. The present comparison with experimental data, indicates nonetheless that these
contributions are of comparable magnitude and cancel each other out roughly for the present
system.
5.2 Structural characterization of HSA in solution
The following Chapter addresses the question, whether polyelectrolyte adsorption to the
protein has an impact on the protein native structure. SANS experiments clarify this
question by comparing results from pure HSA measurements in solution with varying salt
concentrations, to experiments on the PAA-HSA complex. Furthermore, different HSA
samples were studied comparing size and molecular weight, namely (i) purchased HSA
powder from Sigma-Aldrich, (ii) isolated HSA samples from healthy patients and (iii)
isolated HSA from pathological patients, suffering form chronic kidney disease (CKD).
5.2.1 Data treatment and analysis
Prior to data analysis, SANS data have to be reduced and corrected by background scatter-
ing. While the basic reduction steps were presented in Section 4.2.2, the following chapter
will briefly elaborate on the background subtraction procedure and the analysis of the
corrected data by the ATSAS package1.
The q-independent buffer solution scattering is subtracted to obtain otherwise invisible
structural information of the protein. Representative raw neutron scattering data is shown
1ATSAS package is provided by the EMBL Hamburg and can be downloaded from [167].
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in Figure 5.10a). A 4.7 g/L HSA solution in 10 mM MOPS buffer with 10 mM NaCl (brown
symbols) and according buffer solution (blue symbols) are prepared in 100 % D2O. As
expected, the D2O buffer solution scatters uniformly with an intensity of approximately
0.05 cm−1 as reported in literature. [144] At high q values, HSA scattering converges
towards buffer intensities. Figure 5.10b) depicts the HSA scattering after buffer subtraction
(brown circles). However, an incoherent scattering part is still seen in the data that is
owing to hydrogen in the protein, which exchanges with the surrounding solution during
solvation. [168] A constant value is fitted using the high q range of the data after the first
correction step, as indicated by the dotted line, and the intensities were corrected for this
value. The final result (green triangles) is compared to theoretical scattering intensities
calculated from the crystal structure of HSA 2 (solid line).
Figure 5.10: Background correction demonstrated on scattering of HSA in D2O buffer solution.
(a) Raw scattering data of 4.7 g/L HSA in buffer solution (brown) and buffer solution in D2O
with I = 20 mM (blue). (b) After subtraction of the buffer scattering from the HSA data (brown
spheres), a constant incoherent background is fitted (horizontal dotted line), and subtracted
from the solution corrected data. The result (green triangles) coincide well with a theoretical
scattering curve calculated from the crystal structure of HSA (black solid line).
In the following, only solution background and incoherent background corrected data will
be shown, following the same procedure as described above. For parts of the evaluation of
scattering data from HSA, software from the program suite for SANS data analysis ATSAS,
developed by Petoukhov et al., was used. [170] While the mathematical basics underlying
the software are described in publications [171–173], the following section aims at describing
the use of the specific software for the presented study.
2PDB ID: 1AO6 taken from [169].
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Gnom [171] was used to calculate the particle distance distribution function P (r) (PDDF)
by an indirect Fourier transform of the intensity I(q) to determine the radius of gyration,
and the forward intensity I(0) extrapolated to q = 0. The PDDF is defined as: [174]
P (r) = 4pi
∫ ∞
0
I(q)sin(qr)
qr
dr (5.3)
Thus, using the full q-range, P (r) can be an alternative to determine I(0) and Rg (see Equa-
tion (3.51) and Equation (3.52) from Section 3.3.2) applying the following formalism:
R2g =
∫
P (r)r2dr
2
∫
P (r)dr (5.4)
I(0) = 4pi
∫ Dmax
0
P (r)dr (5.5)
These calculations rely on the assumption that P (r = 0) = 0 and on a good approximation
for Dmax, the maximum protein diameter. The quality of Dmax crucially depends on the
quality of the measured data. One criteria is q < pi/Dmax to accurately determine the
largest dimension of the protein. [171]
Another useful software of the ATSAS package is CRYSON. This program evaluates
neutron scattering intensities of a protein in solution with known atomic structure. [173]
Crystallographic data of a protein (such as obtained from the protein database PDB [169])
typically determined by X-rays or NMR, is used to calculate scattering amplitudes. The
hydration shell is taken into account by varying the border layer of solution scattering
density, which can differ from bulk scattering density. Svergun et al. have shown with
small-angle X-ray scattering (SAXS) experiments that the hydration shell has typically
1.05-1.25 times the density of bulk water. [173] Furthermore, theoretical curves can be
calculated for different D2O/H2O fractions, as well as pre-deuteration of the molecule. For
given SANS experimental data, the program can fit the theoretical scattering curve to
measured data by smearing it, using the resolution specifications of the instrument and
then minimizing discrepancy (chi-square value). More details on the software can be found
in Section 8.2 of the Appendix.
5.2.2 Structure of native HSA in solution
HSA was dissolved in buffer solution using either PBS or MOPS as buffer and NaCl
added as salt to adjust ionic strength. The reduction of the raw SANS data is described
in Section 4.2.2 and henceforth, only the background corrected intensities in absolute units
are shown. As described in Section 5.2.1, a set of tools from the SANS analysis software
package ATSAS was used. In Section 8.2 of the Appendix, a more detailed description of
the applied software is performed and the effect of different input parameters is analyzed.
Following this analysis, Gnom and Cryson were applied to an example of actual scattering
data of HSA in 25 mM PBS solution and the differences between the fit results compared.
In Figure 5.11a) experimental intensities of HSA in solution are evaluated against theoreti-
cally calculated data (blue line). Furthermore, two fitting approaches are compared: (i)
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Figure 5.11: Comparison of different fit methods. (a) Experimental data of 12 g/L HSA in
25 mM PBS buffer solution is evaluated using different approaches and compared to theoretically
calculated scattering data using crystal structure information (blue line). Grey solid line
represents a fit by Cryson[173] and the dotted line is calculated using Gnom [171]. (b) Kratky
plot of the profiles from the left panel with according residuals in the bottom panel.
the fit Crystal-Data Fit (grey line) is obtained using Cryson, while (ii) Experimental Data
Fit is calculated using Gnom. Cryson smears the theoretical curves (blue line), using the
resolution function to take the instrumental distortion into account. Also, it accounts for
the hydration shell by surrounding the protein in solution with a border layer of variable
scattering density. [173] As the differences are not clearly visible in the standard represen-
tation, a Kratky plot is shown in Figure 5.11b). I(q) · q2 is plotted over q and a typical
bell-shaped peak followed by convergence towards the q-axis is observed for all curves.
However, significant deviations of the experimental data to the cryson fit are evident.
The conclusion is that the structure of HSA in solution is indeed different to its crystal
structure and not only an effect of instrumental smearing. This observation can reasonably
be explained by the use of different techniques. To obtain crystal data, crystallization of the
protein prior to measurement are necessary, which may alter its structure in comparison
to the dissolved state. The best curve describing the data is the fit by Gnom, where no
crystal data is used as an input. Thus, further evaluation of scattering data in the thesis is
performed by Gnom.
The effect of different buffer and ionic strength on the structure of HSA in solution was
studied and representative results are presented in Figure 5.12. Panel a) shows intensities
of HSA for ionic strengths I = 20 mM and 150 mM and two different buffers MOPS and
PBS. The inset exhibit PDDFs calculated using Gnom3. [171] The theoretically calculated
intensity from crystal data is plotted as a dotted black line. Although the difference between
each sample is not apparent in the standard intensity plot, it is marginally reflected in the
P (r) functions and in the first maximum of the Kratky plot (Figure 5.12b). However, these
3A more detailed explanation of the software is given in Section 5.2.1
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findings are not systematically reflected in the radius of gyration Rg obtained by Gnom
(see Table 5.3).
Figure 5.12: Comparison of native HSA in different buffer solutions with different ionic strengths.
Dotted line is a theoretical intensity calculated from crystal data. The inset of a) shows PDDF
profiles P (R), which reveal a slightly different shape and Dmax. (b) A difference between high
and low ionic strength is also visible in the first maximum in the Kratky plot.
Nevertheless, this observation has been made by other authors, studying the structure of
Bovine serum albumin (BSA) under different salts and ionic strengths. [168] While the
authors interpret the impact of salt as negligible, the Kratky plot does exhibit similar
features as in the present study (see Figure 5.13 bottom panel). [168] Thus, there are
indications that a minor effect of salt concentration on the HSA structure in solution is
present. These differences are, however, difficult to quantify as they are at the margins of
resolution of the method.
Figure 5.13: Scattering of
BSA in solution adapted
from [168]. Top panel shows
BSA intensities measured
at different NaCl concentra-
tion. Kratky plots of BSA
profiles in the present of dif-
ferent salts and salt concen-
trations are presented in the
bottom panel. A deviation
in the first maximum can
clearly be observed.
In general, both fit parameters I0 and Rg obtained from the two different instruments are
in good agreement, with an average value of ∼ 27 Å. Leggio and coworkers have found in a
53
5 Interaction of polyelectrolyte with HSA
SAXS study, very similar values for a HSA of the purity > 96 % that is Rg = 30.2± 0.4 Å.
The derivation of 3 Å can be explained by the difference in protein, as the present study
uses HSA with a purity > 99 %. Additional fatty acids adsorbed on the protein would lead
to an increased Rg. While the values for I0/φ are consistent, molecular weights (MWs)
determined from the forwards scattering deviate significantly from the theoretical value of
the HSA monomer (≈ 66.3 kDa). The calculation of MW, is proportional to the square of
scattering length density contrast ∆ρ as seen in Equation (3.52), which in turn depends
on the hydration state of the protein. When using D2O as a solvent, H-D exchange will
occur and the extent of exchange depends on protein concentration in solution. ∆ρ can
vary between 3.59 × 1010 − 3.30 × 1010 cm−2 with increasing hydration of 90 % −70 %.
The values given in Table 5.3 are calculated supposing roughly an average hydration of
80 %. The uncertainty given for MW in the table only accounts for errors in I0 and
protein concentration. Thus, it is difficult to determine MW of the protein from the SANS
experiment, as also found by Zhang et al.. [168] Further studies on the state of hydration of
HSA will be performed in the following.
Table 5.3: Overview of results obtained for native HSA scattering in solution. Rg and I0 were
obtained using GNOM. [171] MW was calculated according to Equation (3.52) The forward
intensity I0 in the last column is divided by the concentration and relative constant values
as expected are obtained. A plot showing the relation between I0 and concentration is given
in Figure 8.5 in the Appendix.
Instrument Buffer I φ(HSA)±0.08 Rg ± 0.8 I0/φ± 0.04 MW±1
in mM in % in Å in cm−1 in kDa
V16
PBS 25 1.15 27.2 0.63 46
PBS 100 0.92 26.5 0.71 51
MOPS 150 0.86 26.2 0.60 43
KWS-2
MOPS 20 0.36 26.7 0.71 51
PBS 150 0.35 28.8 0.71 50
MOPS 150 0.36 27.2 0.70 50
To summarize, the size and shape of HSA monomers in solution can be well characterized
by SANS experiments. Deviations are observed between the crystal structure and HSA in
solution. By closer inspection, the shape is weakly influenced by ionic strength and choice
of buffer. Rg and I0 are both reproducible quantities, where the first parameter reflects
minor structural changes as induces by different salt concentration.
5.2.2.1 Contrast variation
By varying the D2O to H2O fraction, the scattering length density of the solution can be
changed and thus different contrasts of protein to solvent ∆ρ is created. Inhomogenous
domains within the protein with possibly different scattering lengths can then contribute
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differently to scattering, depending on the protein. Basic principles of this technique are
summarized in Section 3.3.3.
Contrast variation experiments were performed in buffer solutions containing native HSA
at two ionic strengths 20 mM and 150 mM. Absolute intensities of scattering at ionic
strengths 25 mM and 150 mM at three contrasts 100 %, 80 % and 70 % D2O content are
depicted in Figure 5.14 a) and b). Hereby, the intensities in Figure 5.14 b) are divided by
corresponding volume fraction for better comparison of the data.4
Figure 5.14: Series of contrast variation measurements of purchased native HSA in solution with
I = 25 mM (a) and (b) I = 150 mM. D2O/H2O fractions vary from 100 % (grey), 80 % (dark
blue), 70 % (light blue). Intensities in (b) are divided by corresponding volume fraction of HSA
and theoretically calculated data using crystal structure [173] is scaled and plotted as lines on
top for comparison. Derived values for I(0) and Rg fitted by analyzing the Guinier regime are
listed in Table 5.4.
The forward scattering intensity in both series of measurements changes with contrast, as
expected (see Equation (3.57)). The calculated theoretical intensities by Cryson are plotted
on top of the experimental data and show good agreement with the experiments. Further
analysis by determining the forward scattering I0 (see Guinier analysis Equation (3.51))
allow the calculation of the average scattering length ρ¯ as defined in Section 3.3.3. Guinier
fits are shown in Figure 8.6 of the Appendix and according results are listed in Table 5.4.
A plot of the squared I(0) values with according sign of the respective contrast versus
solvent scattering length density ρs allows the derivation of ρ¯ and Vp (see Figure 5.15). The
average contrast scattering length density is derived from the intersection of the fit with the
x-axis and the particle volume from the slope according to Equation (3.57). Additionally,
with the known density of the protein ρ = 1.3 g/cm3, the molecular weight (MW) of HSA
can be calculated from its particle volume by MW = ρ · VpNA. The fits for the two series of
4This step was not necessary for the I = 25 mM measurements, as all experiments were performed
with the same HSA concentration of 12 g/L.
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Table 5.4: Overview of contrast variation experiments performed on native HSA. Values Rg and
I0 are derived using GNOM [171].
Sample D2O Buffer φ(HSA)±0.08 Rg I0 ± 0.02
description fraction in mM in % in Å in cm−1
HSA native∗
100
PBS 150
0.35 28.8 ±0.5 0.25
80 0.38 27.4 ±0.5 0.105
70 0.42 25.8 ±0.7 0.067
HSA native†
100 PBS 25 0.92 27.2 ±0.5 0.85
80 PBS 25 0.92 25.8 ±0.6 0.316
70 PBS 25 0.92 24.4 ±0.8 0.168
Experiments were performed at KWS-2∗ and at V16†, respectively.
measurements at 25 mM and 150 mM are shown in Figure 5.15 and results for ρ¯, Vp and
MW are listed in Table 5.5
Figure 5.15: Analysis of the forward scattering in dependency on contrast. In the y-axis is plotted
the square root of I(0) derived by a Guinier fit shown in Figure 8.6 of the Appendix and normalized
to respective volume fraction. According sign derived from the scattering length particle to
solvent contrast is multiplied to the root of I0. On the x-axis is plotted the solvent scattering
length density ρs. A linear fit following Equation (3.57) yields average scattering length densities
of ρ¯(I = 25 mM) = (2.58± 0.15) · 1010 cm−10 and ρ¯(I = 150 mM) = (2.60± 0.18) · 1010 cm−10
for 25 mM (brown) and 150 mM (green), respectively.
The average SLD ρ¯ obtained for both ionic strengths are around ∼ 2.6 × 1010 cm−2. A
theoretical SLD for HSA can be calculated and corresponds to 1.846 × 1010 cm−2, not
accounting for any H-D exchange. However, H-D exchange is a well known phenomena
for proteins dissolved in D2O [133], and there are 1048 exchangeable hydrogens in one
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HSA molecule. [175] Upon solvation in D2O, up to 90 % of them can be replaced by deu-
terium. [175] The SLD value obtained here would correspond to a theoretical H-D exchange
of ∼60 %, which calculates to ρtheo(60 %) = 2.65×1010 cm−1. [176, 177] The particle volume
derived from the fit however, is significantly lower than a calculated volume. Based on the
primary sequence of HSA and its sum of constituent amino acid volumes, the theoretical
volume is 81000 nm3 and 20 % larger, than found in experiments. Accordingly, the MW
values calculated by experiments of ∼ 50 kDa are significantly lower than theoretical MW
(≈ 66.3 kDa) as also deduced previously in Section 5.2.2. Certainly, uncertainties in ρ¯
are higher here, as only three contrasts were available for fitting. The present study is
nonetheless comparable to results found by Zhang et al. in a combined SAXS/SANS study
of BSA solution. Instead of using contrast variation, they deduced the size and SLD of
BSA by fitting a form factor to single scattering intensities. A H-D exchange of ≈ 70 %
and scattering particle volumes with about 13 % deviation from calculated BSA volumes
were found. [168]
It is further known that the radius of gyration also depends on contrast, as discussed
in Section 3.3.3. Stuhrmann et al. have shown that the radius of gyration Rg,∞ at infinity
contrast can be determined by contrast variation. [132, 133] In Figure 5.16 is depicted a
Stuhrmann plot with a linear fit according to Equation (3.59). A linear dependence of the
square of Rg on contrast is indeed observed and the fits yield Rg,∞ = 29.2 ± 0.9 Å and
Rg,∞ = 32.2± 1 Å for 25 mM and 150 mM, respectively. These values are slightly larger
than the experimentally found radii at maximum contrast of 28.8 Å and 27.2 Å.
Figure 5.16: Stuhrmann plot of the two contrast series of HSA in solution with I = 25 mM
(brown) and I = 150 mM (green). A linear fit using Equation (3.59) was performed and the
according Rg,∞ obtained are listed in Table 5.5.
In conclusion, minor difference in size, MW and SLD of HSA in 25 mM and 150 mM is seen
in the performed experiments. However, the deductions obtained here contain relatively
57
5 Interaction of polyelectrolyte with HSA
Table 5.5: Fit parameters derived from I(0) analysis in Figure 5.15 and the Stuhrmann plot
in Figure 5.16.
Ionic strength Average SLD ρ¯ Particle volume Vp MW Radius Rg,∞
in mM in 1010 cm−2 in nm3 in kDa in Å
25 2.58 ± 0.15 65.000 ± 5000 51 ± 2 29.2 ± 0.9
150 2.60 ± 0.18 52.000 ± 5000 49.8 ± 2 32.2 ± 1
large errors and more experiments at different contrasts are necessary to improve precision
of the obtained values. The extend of H-D exchange of the protein in D2O solution could be
determined to 60 %, which is similar to what has been found for BSA. [168] In general, all
results are in accordance with expected parameters of HSA known from the crystallographic
structure and a deviation from such structure after solvation is thus reasonable.
5.2.3 Structural investigation of patient HSA
Another interesting aspect to study with regards to the clinical question of how the patho-
logical condition of patients influence the albumin structure is addressed by SANS. The aim
was to investigate whether HSA isolated from pathological patients suffering from chronic
kidney disease (CKD) is modified in a structural way in comparison to samples obtained
from healthy control patients. Thus, proteins were isolated from different subjects and
additionally compared to purchased samples under different ionic strength conditions.
Scattering intensities of isolated HSA samples obtained from healthy control patients and
pathological patients, suffering from CKD, are plotted in Figure 5.17. The intensities of the
samples were divided by I(0) (obtained from a fit by GNOM, see Section 5.2.1) for better
comparison. Native HSA sample in solution is plotted as a reference (brown line). Two
control samples C-A and C-B were isolated from different healthy individuals (green circles
and triangles). All samples referring to CKD patients originate from HSA isolated from the
same pathological patient, including the complexed HSA sample with 1 g/L PAA.
The main observation here is made for the low q-regime, where scattering of all profiles
differ significantly from the intensity scattered by the purchased HSA sample. An upturn
of intensity is especially pronounced for the CKD sample at I = 20 mM (blue) and for
the complexed HSA-PAA sample (violet). As the scattering profile at intermediate and
high q still follows the native HSA profile, it is save to assume that the form of the protein
is unchanged. Thus, the upturn in the low q range points towards larger particles in the
solution. A possible explanation is the existence of agglomerations of HSA in solution.
The magnified view on the low q-regime in Figure 5.17b) reveal that the difference to
native HSA is more pronounced in the pathological samples (blue symbols) rather than the
control samples (green symbols). Thereby complexation with PAA does not seem to have
an additional effect on the pathological HSA samples.
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Figure 5.17: Scattering intensities of HSA isolated from pathological CKD (open blue and yellow
circles) and healthy control patients (full green circles and triangles) at different ionic strengths
are shown. Control A and B were obtained from two different healthy individuals. Scattering
profile from purchased HSA at 20 mM ionic strength is plotted as a comparison (brown line).
One complexed HSA-PAA sample using HSA from CKD patient is shown for I = 20 mM (open
violet circles). All intensities were divided by their forward scattering intensity I(0) for better
comparison. Panel (b) shows a magnified view of the scattering in low q-range.
All scattering data were fitted using Gnom to determine the radius of gyration Rg and results
are summarized in Table 5.6. The Rg values obtained from the control samples C-A and C-B
coincide well within the limits of error. In the case of pathological samples, the coexistence
of another scattering species leads to larger uncertainties of Rg. Thus, the difference seen in
Rg between different salt concentrations and after PAA complexation cannot be interpreted
explicitly. Additionally, a Krakty plot reveals possible tertiary structure changes which
would be reflected in the first maximum (see Figure 5.18). However, no significant structural
differences can be detected between all studied samples. Only a minor difference is seen
between samples with different ionic strength, independent of the complexation state.
Table 5.6: Overview of samples and experimental conditions with corresponding results of radius
of gyration Rg obtained from the fits.
Sample C-A C-B P-HSA P-HSA P-HSA + PAA
Ionic strength in mM 150 PBS 150 PBS 150 PBS 20 MOPS 20 MOPS
Radius Rg ± 1 in Å 29.4 28.8 27.6 29.7 30.3
C-A and C-B samples corresponds to HSA isolated from two different healthy individuals as control samples. P-HSA
samples corresponds to HSA samples that were isolated from one individual of pathological condition (suffering from CKD)
in a single experimental procedure.
To conclude this section, it can be stated that the tertiary structure of HSA is preserved for
all protein samples analyzed in the present study. A clear difference emerges in the low
q-regime of HSA isolated from pathological patients to native HSA that might indicate
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Figure 5.18: Kratky plot of the
normalized intensities shown
in Figure 5.17. The profile of
Control A was left out for bet-
ter clarity, as no large difference
is seen to Control B scattering
profile.
the presence of larger agglomerates that is not present in the native HSA solution. Indeed,
modifications of HSA have been found in the blood of patients suffering from CKD, but
the consequences of these modifications on the interaction of HSA with other proteins or
ligands are unclear. [178] It is therefore possible that these modifications might change the
protein surface charge distribution and thus leading to aggregation. Unfortunately, the
SANS experiments performed give no direct proof of such an effect and more studies are
necessary to confirm this assumption.
5.3 Structure of the protein-polyelectrolyte complex
The next step in spatial characterization of the system is to investigate, whether structural
changes due to adsorption of PAA is induced to the native HSA structure. PAA concen-
trations were adjusted relative to the HSA concentration with molar ratios 8:1 and 2:1 of
PAA to HSA, respectively. The scattering of higher concentrated, pure PAA solution in
20 mM MOPS buffer was measured as reference. The higher concentration was chosen to
achieve acceptable scattering intensities, as PAA is a rather small molecule and scatters
only weakly. The total concentrations were 4.7 g/L of HSA for all samples and 1 g/L and
0.25 g/L PAA for the two different molar ratios, respectively. Two ionic strengths 20 mM
and 150 mM were adjusted using 10 mM MOPS buffer and additional NaCl. Additionally,
the effect of divalent ions, namely MgCl2 and CaCl2, on the complexation of PE-protein
was studied at a total ionic strength of 20 mM. 5 All experiments were performed at 37 ◦C.
Raw scattering data (prior to background correction) of pure HSA solution, pure PAA
solution and HSA-PAA complex with molar ratio 1:8 and ionic strength I = 150 mM are
shown in Figure 5.19a). A noticeable observation is the forward scattering of free PAA
molecules in solution. This is due to the polyelectrolyte effect as observed in literature. [179]
In the high q-regime, an almost constant scattering intensity of ≈ 0.058 cm−1 is found.
5The ionic strength were achieved with 1 mM MgCl2 + 2.5 mM CaCl2 + 10 mM MOPS = 20 mM
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Figure 5.19: Structure of HSA complexed with PAA in comparison with HSA in solution. (a)
Raw scattering data without background correction are shown for buffer (blue triangles), PAA
scattering in solution (blue rectangles), native HSA (brown circles) and HSA complexed with
PAA (green circles). Vertical dashed lines indicated the combination q ranges measured at
different detector distances (20 m, 6 m and 1 m). (b) Background corrected scattering profiles
from native and complexed HSA are compared to the theoretical crystallographic profile. The
intensities of the complex are corrected for scattering of free PAA in the solution.
Subtracting the intensity of buffer scattering (≈ 0.049 cm−1), the resulting intensity
corresponds very well with a theoretically approximated forward scattering intensity I0 ≈
0.01 of PAA molecules calculated using Equation (3.52). 6 The scattering contribution
of free PAA in the solution is also observed in the raw scattering data of HSA-PAA
complex solutions in Figure 5.19a) and needs to be subtracted when analyzing the scattering
contribution of the complex. The intensity of that contribution thus calculates to:
IHSA-PAA(q) = [Itot(q)− (1− φHSA)Ibuffer(q)]︸ ︷︷ ︸
total measured scattering intensity
− cPAA
cref
[IPAA − (1− φPAA)Ibuffer(q)]︸ ︷︷ ︸
scatteing of free PAA in solution
(5.6)
where the first term describes the buffer corrected total scattering intensity and the second
term accounts for the buffer corrected scattering of free PAA molecules in solution. The
free PAA concentration is calculated based on the previous findings by ITC and computer
simulation that binding occurs at a 1:1 ratio. Thus, the scattering of free PAA IPAA is
scaled from the reference concentration cref to the calculated free PAA concentration cPAA.
The result is shown in Figure 5.19b) as green data points. After correction, the scattering
of the complex hardly differs from the scattering profile of native HSA at I = 20 mM and
all curves overlap with theoretically calculated intensities (solid line).
This procedure was applied to each data set. Due to limited experimental time, low q-regime
measurements were conducted only for two more samples, namely the native HSA sample
6Equation (3.52) is used to calculate the forward scattering I(0) of PAA with ν ≈ 0.71, MW =
1800 g/mol, c = 8 g/L and ∆ρ ≈ 2.93cm−1.
61
5 Interaction of polyelectrolyte with HSA
and a HSA-PAA complex sample with molar ratio 1:2. An overview of all scattering curves
is given in Figure 5.20a). Reliable scattering data can be obtained up to q ≈ 0.4 Å−1. In
the intermediate and high q-range, no significant difference to the native HSA data (brown
circles) is observed after complexation. For a molar ratio of 1:2 HSA-PAA and I = 150 mM,
signatures for aggregation are present, even after the subtraction of free PAA scattering. It
is possible that higher salt concentration in the solution leads to an increased screening of
the repulsive charges of the complex and thus enables an attractive interaction.
Figure 5.20: Structure of HSA-PAA complex in comparison to HSA in solution. (a) Scattering
data taken at 37 ◦C and I = 20 mM. (b) Kratky plot of the scattering data shown in a).
Table 5.7: Overview of neutron experiment and corresponding fit results for HSA complexation
with PAA at two ionic strengths using different salts. All experiments were carried out at 37 ◦C
with 10 mM MOPS as buffer solution.
HSA:PAA Ionic strength c(HSA) c(PAA) Rg ± 0.8 I0 ± 0.01
ratio in mM in g/L in g/L in Å in cm−1
1:0 20 4.7 0 26.7 0.26
1:0 150 4.75 0 27.2 0.26
1:8 20 4.7 1 26.5 0.25
1:8 20† 4.7 1 26.4 0.26
1:8 150 4.7 1 28.4 0.26
1:2 20 4.7 0.25 27.3 0.26
1:2 150 4.7 0.25 28.1 0.28
† This sample contains divalent ions MgCl2 and CaCl2 that was added to the MOPS buffer solution
The tertiary structure of the HSA-PAA complex is investigated in a Kratky plot (see Fig-
ure 5.20b). For clarity, only selected profiles are shown.7 It is quite evident that binding of
7The data not shown here are depicted in Figure 8.7 in the Appendix.
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PAA to HSA does not effect the protein structure significantly. A minor difference is only
seen between different high ionic strength measurement. This finding is reflected in the
fitted radius of gyration Rg as well, which are listed in Table 5.7. Here, neither molar ratio
nor the valency of the salt seems to have an impact on Rg. A difference of about 1.5−2 Å−1
enlargement of Rg is found for the increase of ionic strength in the solution. However, this
difference is at the margin of resolution and interpretation must be conducted with care.
Another fit parameter of interest is the forward scattering intensity I0, as it gives the
molecular weight of the complex according to Equation (3.52). For the scattering of
pure HSA in solution, one obtains MW(60 %) = 45 kDa for 60 % of H-D exchange
and MW(90 %) = 56 kDa for 90 % exchange respectively. These values are in line
with the MW values determined by contrast variation in Section 5.2.2.1 and Table 5.5.
Nonetheless, no change in I0 with adsorption of PAA is found in the present study. This
is a reasonable finding, as contribution of free PAA to scattering is only about 0.01 cm−1
and thus the adsorbed PAA intensity with much lower concentration can be approximated
by ≈ 0.0013 cm−1. This intensity is within the margins of error of dI0 = 0.01 cm−1. As a
result, it can be concluded that HSA structure is not altered upon PAA adsorption and the
interpretation of ITC data in the previous Sections are valid.
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6 Binding of uremic toxins to HSA
The second part of this thesis explores the uptake of two uremic toxins by HSA. These
toxins are small, hydrophobic molecules and thus other contributions to interaction can be
explored. Beside the verification of the stability of HSA upon adsorption, SANS studies
of high concentrated solutions were carried out to investigate the interparticle interaction
between proteins loaded with toxins.
6.1 Thermodynamic analysis of binding
Systematic series of ITC experiments were performed with high (I = 150 mM) and low
(I = 20 mM) ionic strengths and three different temperatures comprising room temperature
25 ◦C, a intermediate temperature 30 ◦C, and the physiological temperature 37 ◦C. The
experiments were performed at pH 7.2 in buffer solution. Finally, the aspect of protein
modification on the binding affinity of toxins is evaluated.
6.1.1 Binding of Phenylacetic acid (PhAA) to native HSA
Typical raw data with ITC titration peaks for adsorption (black curves and points) and
dilution (blue curves and points) is shown exemplarily for the adsorption of PhAA to native
HSA in Figure 6.1a). The integrated isotherms were fitted after subtraction of dilution with
either a Single set of independent sites (SSIS) model, Sequential binding sites (SBS) model
or Two set of independent binding sites (TSIS) model 1 in Figure 6.1b).
All measured signals were weakly exothermic and exhibit similar monotonic curve progression
as shown in Figure 6.1b). This result is typically observed in the adsorption of small
hydrophobic molecules to HSA in other studies as well. [31, 87, 180] Because the overall
heat is rather small, dilution must be subtracted carefully as an additional heat signal may
affect the results of the fits.
6.1.1.1 Evaluation of ITC data
The evaluation of ITC data is demonstrated on the example of PhAA adsorption to native
HSA. In Figure 6.1c) a binding isotherm is shown for adsorption at 25◦C and 20 mM salt
and corresponding fits with the two models described in Section 3.2 to evaluate the quality
of the fits. Two fit curves for fixed N = 1 and N = 2 (dotted and dashed line respectively)
1All models were fitted using the implemented ITC Data Analysis software for Origin by MicroCal.
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Figure 6.1: PhAA adsorption to native HSA. (a) Calorimetric titration curves are shown for
adsorption (black line and symbols) and the corresponding heats of dilution (blue line and
symbols) at I = 20 mM and T = 37 ◦C. (b) Dilution corrected isotherms with corresponding
fits are shown and the data for 150 mM is compared to 20 mM at 37 ◦C. (c) The quality of
different fit models are demonstrated on the example of 20 mM and 37 ◦C data in a typical ITC
plot (top) and a semi-logarithmic plot of |Q| (bottom). Reprinted with permission from [181].
Copyright 2017 RSC Advances.
with the SSIS model are compared to the SBS model for two sites. As the curves can hardly
be discriminated in the common ITC diagram (as shown in the top of Figure 6.1c), an
alternative plot of the absolute value of ITC heats |Q| on a logarithmic axis (bottom figure)
is introduced. At low molar ratio, all fitted curves coincide with the data. However, at
higher PhAA concentrations, deviations between the different fits become more obvious
and the importance of the high molar ratio data is evident. For the given case, data points
are clearly best described by the SBS model, pointing towards the existence of two different
binding sites of the HSA for PhAA. In the following this semi-logarithmic plot is used to
determine the best fit available.
A few more examples are shown in Figure 6.2. Comparing the different binding isotherms and
their fitting, it becomes evident that binding behavior is different for different temperatures
and ionic strengths. At high temperature, both models converge towards each other
(see Figure 6.2b) and c). The affinity Kb2 to bind a second PhAA molecule to HSA becomes
very weak for 20 mM salt and 37◦C and vanishes for higher ionic strength at the same
temperature (see Figure 6.2c) and Table 6.1 and Table 6.3). In this case, the data can be
well described with the SSIS model with N = 1. For other cases, where two binding sites
are present, the SSIS model permanently underestimates binding affinity and enthalpy and
produce a rather large error as seen in χ2. A comparison of the results of the fits is given
in Table 6.1.
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Figure 6.2: Binding model analysis of PhAA adsorption to native HSA. Logarithmic plots as
shown before to discriminate the quality of two binding models SSIS (solid line) and SBS (dotted
line). Three representative binding cases are shown for I = 20 mM at (a) 30◦C and (b) 37◦C
and for (c) I = 150 mM and 37◦C. Reprinted with permission from [181]. Copyright 2017 RSC
Advances.
6.1.1.2 Influence of temperature on the strength of binding
The dependence of the adsorption of PhAA onto HSA on ionic strength and temperature
were studied to conduct a full thermodynamic analysis. Measurements at different tempera-
tures are depicted exemplarily in Figure 6.3 for I = 20 mM and 150 mM ionic strength. The
best fits determined as explained before are depicted as lines. In contrast to the adsorption of
polyelectrolytes (PE) to HSA that has been investigated in earlier studies, [149] the present
binding curves do not exhibit a strong dependence on temperature for either 20 mM or
150 mM ionic strength. Nevertheless, a consistent change in the curvature of the isotherms
is obvious and also reflected in the binding parameters listed in Table 6.2.
In general, the binding affinity decrease with increasing temperature as has been observed
in several cases of adsorption of small molecules to HSA. [24, 31, 33, 85] For example, Zaidi
et al. have studied interaction between hippuric acid (HA) and HSA and their dependence
on temperature using steady state fluorescence quenching measurements and ITC. The
ITC data was analyzed using the SBS model likewise and reveal common trends for the
dependence of the binding constant on temperature.
In a direct comparison of the literature data with the present results, binding affinity of the
first binding site very much coincides in trend and magnitude as shown in Figure 6.4 (brown
triangle and spheres). [31] For the second binding site, a minor dependence on temperature
was observed in the case of PhAA adsorption to HSA. The dependence on temperature can
be analyzed according to van’t Hoff’s law (see Equation (3.25)).
Van’t Hoff plots of the first and second ligand binding process are displayed in Figure 6.4
and the results summarized in Table 6.2. The analysis of the van’t Hoff enthalpy done here is
67
6 Binding of uremic toxins to HSA
Table 6.1: Thermodynamic parameters obtained with different fit models for the different experi-
mental conditions in Section 3.1.
I T Model Ntotal ∆H1 Kb1 · 103 ∆H2 Kb2 · 103 χ2∗
(mM) (◦C) (kJ/mol) (M−1) (kJ/mol) (M−1)
20 25
One Site
1 -23.0±0.2 17.3±0.4 - - 80
2 -11.0±0.1 21.1±0.8 - - 144
Sequential Binding 2 -20.1±0.6 21.8±1 -8±1 0.95±0.3 50
20 30
One Site 1 -24.9±0.3 12.9±0.4 - - 109
Sequential Binding 2 -20.7±0.7 17.4±0.9 -12±1 0.9±0.2 50
20 37
One Site 1 -29.4±0.6 10.3±0.2 - - 37
Sequential Binding 2 -26.8±0.6 11.5±0.5 -0.7±0.3 0.84±0.3 27
150 37
One Site 1 -12.6±0.2 5.6±0.1 - - 8
Sequential Binding 2 -12.7±0.3 5.5±0.2 5±3 0.14±0.05 8
χ2 is the error of the fit obtained by the implemented ITC Data analysis software by
MicroCal.
only semi-quantitative since a fully quantitative determination would require measurements
at far more temperatures than done here. For the toxin IDS, the enthalpy as measured
directly by ITC and van’t Hoff enthalpy coincide quite well and ∆HITC is in the present
study a good measure for the enthalpy of the binding. In the following, the focus lays on
the analysis of the binding free energy ∆Gb calculated using Equation (3.20).
Another interesting feature is observed for I = 150 mM, where a decrease of a second
ligand binding with temperature is measured. At high ionic strength and temperature
both binding enthalpy and binding constant almost vanishes pointing towards an increased
Coulombic screening and thus a weakening of the interaction. This is a plausible explanation
for the results obtained recently by Jankowski et al. who measured almost a doubling of
released PhAA during hypertonic predilution hemodiafiltration. [30] Furthermore, it was
shown in the previous Section 5.1 that ionic strength does contribute significantly towards
charge-charge interaction between protein and the polyelectrolyte.
6.1.1.3 Influence of ionic strength on binding
To gain more detailed insight into the effect of ionic strength, three additional measurements
were performed at 37◦C and I = 50 mM, 70 mM and 100 mM (with ITC parameters
listed in Table 1). Exemplary isotherms are presented in Figure 6.5, while in the inset
binding constant Kb1 is plotted against ionic strength. The binding energy ∆Gb1 is found
to be lowered only by 1.5 kJ/mol when adding salt in a wide range from 20 to 150 mM
concentration. This small effect due to ionic screening demonstrates that the net electrostatic
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Figure 6.3: PhAA adsorption to native HSA. Absolute heats |Q| are shown for ionic strength I =
20 mM and 150 mM at different temperatures and respective fits are displayed. Reprinted with
permission from [181]. Copyright 2017 RSC Advances.
Figure 6.4: Effect of tempera-
ture for PhAA binding to na-
tive HSA. Binding affinities for
first (filled symbols) and second
binding process (open symbols)
are shown in a van’t Hoff plot
for I = 20 mM (brown) and I
= 150 mM (blue) with corre-
sponding fits according to Equa-
tion (3.25). Literature data for
HA-HSA binding with 20 mM
sodium phosphate buffer (pH
7.4) are included as triangles
with dotted lines as guideline for
the eye. [31] Reprinted with per-
mission from [181]. Copyright
2017 RSC Advances.
contribution to binding is rather weak when compared, for instance, to the interaction of a
PE chain to HSA. [149] Hence, it can be tentatively concluded that hydrophobic binding
plays the dominant role.
A simple Debye-Hückel (DH) perspective for screened electrostatic interactions sketched
in the following supports this conclusion. For this, consider the DH interaction between
two spherical molecules i and j of valence zi and zj and radii Ri and Rj , respectively, at a
binding distance rbind = Ri +Rj , which reads: [118, 182–184]
∆GijDH/kBT =
zizjλB
(Ri +Rj)(1 + κRi)(1 + κRj)
. (6.1)
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Figure 6.5: Effect of ionic strength
at 37◦C. Binding isotherms and
corresponding fits for a series of
ionic strengths from I = 20 mM -
150 mM are shown. The inset dis-
plays the binding affinity in depen-
dence of ionic strength. Reprinted
with permission from [181]. Copy-
right 2017 RSC Advances.
Here, κ =
√
8piλBcsalt is the inverse Debye screening length and λB ≈ 0.7 nm is the relevant
Bjerrum length.
Furthermore, two competing, leading order electrostatic contributions are assumed: first,
the local attraction of the negatively charged ligand to the binding site at which a few
positively charged amino acids are clustered together. The study on binding between PAA
and HSA in the previous Chapter, for instance, suggests about 2-3 positive charges involved
in binding near the Sudlow II site. Second, the overall repulsion of the ligand is the sum of
all the other negative charges on HSA.
For the attractive term the size of the charged groups at the binding site is assumed to be
on atomistic scales and the same as the ligand, i.e., RPhAA = Rsite ≈ 0.2 nm, such that
the binding distance is Rsite +RPhAA ≈ 0.4 nm. The ligand valency is zPhAA = −1, and
with presumably two positives charges, zsite = +2. According to Equation (6.1) then the
attractive term contributes approximately −7 kJ/mol to the binding energy, decreasing in
absolute magnitude with increasing ionic strength to about −5.5 kJ/mol.
For the repulsive contribution, the protein is modeled as a charged sphere of radius
RHSA ≈ 3.25 nm [185, 186] and a net charge of −14 e. 2 Thus, to compensate for the
positive site, a remaining net valency of zHSA = −16 is obtained which is assumed to be
located in the HSA center of the protein for simplicity. An illustration of the model is
shown in Figure 6.6.
Due to the relatively large size of HSA, the electrostatic coupling [187] is weak and within
the validity of the DH treatment. The distance between the bound ligand and the protein
center-of-charge is RHSA + RPhAA ≈ 3.45 nm. According to Equation (6.1) this leads
to a repulsive contribution of ≈ +3 kJ/mol at the lowest, and decreasing rapidly to only
≈ +1.5 kJ/mol at the highest salt concentration. Hence, the net electrostatic interaction
∆Gel = ∆GHSA−PhAADH +∆G
site−PhAA
DH ' −4±1 kJ/mol is attractive and small compared to
2The number of charges of the protein can be calculated from the crystal structure.
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Figure 6.6: Schematic illustration of
the model assumed to calculate the
Coulombic contribution. The grey
sphere represent HSA with −16
charges located at its center, orange
sphere marks positive binding site
on the protein and the green sphere
represents the PhAA toxin bearing
two negative charges.
the total experimental binding energies that are in the range between −25 and −23 kJ/mol
(see Table 6.2), decreasing with increasing salt concentration.
Clearly, these numbers are highly approximative as, for instance, HSA is non-spherical
and detailed charge asymmetry and excluded-volume effects on screening [188] have been
neglected. However, the estimates exemplify at least some order of magnitude and trends.
The estimated attractive electrostatic contribution (between PhAA-site) to the binding
is actually similar to monovalent ion pairing affinities found in explicit-water computer
simulations. [189] While the salt concentration dependence should be qualitatively correct,
quantitative details are expected to be more complex than in the simple DH perspective
due to very local hydration and polarization effects. [189–191]
It can be concluded that the electrostatic interaction is small and thus the major contribution
must be of hydrophobic nature, stemming from interactions of the aromatic compound of
PhAA with the binding site. The total binding free energy can then be formally expressed
as:
∆Gb = ∆Gphob + ∆Gel (6.2)
where ∆Gphob is the attractive hydrophobic contribution and ∆Gel the net electrostatic
interaction. Using the ∆Gb1 values in Table 6.2 and subtracting the approximated values
for ∆Gel mentioned above, a hydrophobic contribution of the order of about −19±1 kJ/mol
is obtained. The latter has comparable magnitude than the binding free energy calculated
in explicit-water computer simulations of hydrophobic pocket-ligand binding at 298 K in
pure water and with similar ligand size as in the present study. [192] It is also of comparable
magnitude than the transfer free energy of a single benzene molecule from liquid water
into its own liquid phase. [193] Interestingly, the enthalpy calculated in the explicit-water
simulations [192] is ∆H = −29 ± 17 kJ/mol and thus has the same sign and order of
magnitude than ∆HITC = −20.3± 0.6 kJ/mol measured in experiments with 20 mM salt
(see Table 6.2). This enthalpic signature is the reason for the inverse temperature dependency
of ∆Gb where the effect of hydrophobic attraction weakens with increasing temperature.
Note that this is actually in contrast to what is typically known for hydrophobic association
of simpler systems, which are entropy-driven [194] and is argued to be due to the concave
geometry of typical hydrophobic binding pockets. [192, 195–198]
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6.1.1.4 Binding of Phenylacetic acid to modified HSA
In the following, the effect of carbamylation of HSA through urea [39] on the binding affinity
to PhAA under the same conditions as in the previous section is studied. This in vitro
modification of HSA is known to be found in patients suffering from chronic renal failure
conditions, where the urea plasma concentration is chronically elevated. [39] To study the
urea-modification on the binding behavior of PhAA to HSA, experiments are performed
again at I = 20 mM and I = 150 mM at the same three temperatures as before. Binding
isotherms and corresponding fits are displayed in Figure 6.7. Results from the fits are
summarized in Table 6.2.
Figure 6.7: Effect of HSA urea modification on PhAA adsorption. Isotherms for adsorption of
PhAA upon urea modified HSA for (a) I = 20 mM and (b) I = 150 mM at different temperature
is shown. Reprinted with permission from [181]. Copyright 2017 RSC Advances.
For low ionic strength, only weak dependence of binding on temperature is observed for PhAA
interaction to urea modified HSA, while the strength of binding is principally unchanged. At
high ionic strength and physiological condition, binding is even more weakened compared to
I = 20 mM for the modified system. Binding isotherms are equally exothermic and exhibit
similar curve shapes as in Figure 6.3. The binding affinity of the urea modified system to
the native HSA system is compared for the first binding process and represented in a van’t
Hoff plot in Figure 6.8.
For the binding of the second ligand at 20 mM salt, no pronounced temperature dependence
is observed in both of the systems (see Table 6.2). In both cases, binding of the second
ligand is associated with a rather small affinity compared to the error of fitting. As a result,
it is difficult to resolve a difference in binding affinities in the modified or native system or
a corresponding temperature dependence.
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Figure 6.8: Effect of HSA urea
modification on PhAA adsorp-
tion. Van’t Hoff plot of the
first binding process for native
(filled symbols) and urea modi-
fied HSA (open symbols) with
according fits. Reprinted with
permission from [181]. Copy-
right 2017 RSC Advances.
6.1.2 Binding of Indoxyl sulfate (IDS) to native and modified HSA.
The adsorption of IDS to native and modified HSA was systematically studied at two ionic
strengths I = 20 mM and 150 mM and at three temperatures using ITC. Raw titration
peaks and integrated heats for the adsorption of IDS to native HSA are depicted in Figure 6.9.
Figure 6.9: Interaction of IDS with native HSA. (a) Titration peaks and integrated heats for I =
20 mM at 37◦C. (b) Dilution corrected isotherms with corresponding fits at 37◦C and 20 mM
and 150 mM. (c) Temperature series of adsorption for I = 20 mM. Reprinted with permission
from [181]. Copyright 2017 RSC Advances.
Using the logarithmic representation, exemplary adsorption isotherms and according best
fits for adsorption to native and modified HSA are depicted in Figure 6.10. Again all
adsorption processes show similar exothermic isotherms as observed for PhAA adsorption
in the section above. An increase in ionic strength from 20 mM to 150 mM show the same
effect but overall weaker as observed before as shown in Figure 6.9b). However, in the
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standard ITC plot in Figure 6.9c), temperature differences between different isotherms
are not clearly visible. Therefore logarithmic plots of isotherms and corresponding fits are
shown exemplarily for I = 150 mM and the two HSA types in Figure 6.10. Further isotherms
of adsorption at 20 mM salt are very similar and can be found in Figure 8.11 of the Appendix.
Figure 6.10: Adsorption of IDS to HSA at I = 150 mM. Temperature series and corresponding
fits using the TSIS model are shown exemplarily in the logarithmic plot binding to (a) native
and (b) modified HSA. Reprinted with permission from [181]. Copyright 2017 RSC Advances.
Here the necessity to use a two site adsorption model is clear. As demonstrated in the case
of IDS adsorption to native and modified HSA at 37◦C and I = 150 mM in Figure 6.11, the
data can neither be described by the SSIS (dotted line) nor the SBS (dashed line) model.
There are clearly two binding sites present for IDS with different binding stoichiometry.
Using the Two set of independent sites TSIS model (solid line), ITC isotherms can be very
well described at all measuring conditions. However, the number of IDS molecules adsorbed
at the second site N2 cannot be well determined by a fit of the ITC data. Residual errors
for fits with different fixed parameter N2 (ranging from one to three) show no significant
change. It is however not surprising that fitting a monotonic curve with six parameters
implies the risk of fitting too many free parameters.
Several studies on the adsorption of IDS to HSA confirm the existence of two binding sites
with different binding affinity. [24, 85] Crystallographic analysis of IDS complexed with
HSA suggests that one IDS molecule binds to subdomain III-A while two molecules bind
to subdomain II-A of HSA. [84] Sakai et al. measured IDS adsorption on HSA at 25◦C
and 67 mM phosphate buffer at pH 7.4 using equilibrium dialysis. They found two binding
sites with N1 = 1 and N2 = 3 for high and low affinity binding site, respectively. [24]
A more recent study from Watanabe et al. using ultrafiltration found at same pH and
temperature but different buffer, a slightly lower N2 = 1.6. [85] Based on these findings,
it appears reasonable to fix N2 between one and three and average the results. As the
residuals between each fits are small (see Figure 6.11b), the standard deviation was used
as error for each averaged parameter. Thus, even with an uncertainty of N2 = 2± 1, the
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Figure 6.11: Best fit evaluation to analyze IDS binding to HSA. Quality of different fit models and
parameters are demonstrated by comparing three models SSIS (dotted line), SBS (dashed line)
and TSIS (solid line) for I = 150 mM and 37◦C. Beneath the graph is depicted the residual errors
for TSIS fits with different fixed N2 values. Reprinted with permission from [181]. Copyright
2017 RSC Advances.
binding constants kb2 obtained are robust and reliable. However, the binding enthalpy ∆H2
is strongly correlated with the fit parameter N2 and errors for ∆HITC2 and consequently
∆S2 are accordingly large. All results obtained from the fits are summarized in Table 6.3.
Binding of IDS to HSA is generally an order of magnitude stronger than PhAA to HSA in
all measured cases. However, caution is required when comparing a macroscopic binding
constant Kb to a microscopic binding constant kb. The microscopic constant k1 for exam-
ple describes explicitly the binding process of N1 ligands to Site 1 while the macroscopic
constantKb1 assumes binding of either one of the two potential ligands to any of the two sites.
The effect of urea modification is rather small. The van’t Hoff analysis comparing native to
urea modified HSA reveal temperature dependence of binding for both binding sites, while
the dependency is more pronounced for the high affinity site rather than the low affinity site
(Figure 6.12). The binding enthalpies for the high affinity site ∆HITC1 measured directly
by ITC agree well with the binding enthalpies derived from the van’t Hoff plot (see Table 6.3).
A plot of all results comparing the effect of urea modification on the adsorption of PhAA
and IDS is shown in Figure 6.13. Additionally, the present results are put into context
to earlier investigations on the interaction between a multiply charged "middle molecule",
namely a polyvalent polyacrylic acid (PAA) chain with HSA, to gain a deeper insight into
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Figure 6.12: Van’t Hoff plots
for IDS interaction to HSA.
High and low affinity binding
sites comparing native (filled
symbols) and modified (open
symbols) HSA are shown for
I = 20 mM (brown) and
150 mM (blue) with correspond-
ing fits. Reprinted with permis-
sion from [181]. Copyright 2017
RSC Advances.
different contributions to binding. [149] In Figure 6.13 the binding affinity of the small
toxins IDS and PhAA to HSA exhibit in all cases moderate decreasing binding affinities
to both native and modified HSA while binding of PAA is strongly weakened due to a
decreasing counterion-release entropy with rising salt concentration (see Section 5.1). [149]
For the present ligands, the hydrophobic interaction plays a dominant role in the binding
process as expected.
A characteristic effect for the adsorption of monovalent ligands to proteins is the so called
enthalpy-entropy compensation (EEC), which is revealed when measuring temperature
dependence of the interaction (see Figure 6.13 b). Here the slope of the entropy contribution
T∆Sb plotted versus the enthalpy ∆HITC for the first binding process is near unity as
indicated by the broken line, which is often interpreted as complete EEC compensation.
This effect is commonly involved in interactions between small ligands and proteins and has
thus gained more attention recently by several authors. [33, 180, 199, 200] Even though
controversies exist for the specific contributions to the EEC effect, it is generally recognized
that strong but noncovalent ligand binding to a protein gives rise to a higher enthalpic
contribution and is at the same time associated with less flexibility and therefore lowers
entropy. In particular, the dissociation of water molecules from the ligand into bulk upon
binding of the ligand in a hydrophobic cavity leads to favorable enthalpy contributions
with an opposing entropic contibution. It is remarkable that this effect is well observed
in the simulations of a ligand-cavity model system by Setny et al. [192] For the present
ligands, it is not surprising that hydrophobic interaction plays an eminent role in the binding
interactions. Furthermore, EEC is clearly reflected in the free energy of binding ∆Gb which
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Figure 6.13: Binding parameter overview for the first binding process and high affinity site. (a)
Ionic strength dependence and (b) enthalpy-entropy compensation for adsorption of PhAA
(brown), IDS (green) and PE (blue) to HSA. Full and empty symbols are native and modified
HSA. Spheres and rectangles represent in (a) 25◦C and 37◦C and in (b) I = 20 mM and I =
150 mM respectively. The dotted lines are guidelines for the eye and have a slope of unity in (b).
Reprinted with permission from [181]. Copyright 2017 RSC Advances.
is almost invariant with temperature in all measured cases (see Table 6.2 and Table 6.3).
For the polyelectrolyte however (blue symbols in Figure 6.13b)), the EEC effect cannot be
observed. Here charge-charge interaction and the resulting release of counterions are the
leading terms rather than hydrophobic interaction.
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Table 6.3: Thermodynamic parameters for the binding of IDS to native and urea modified HSA at
25◦C, 30◦C and 37◦C and ionic strengths 20 mM and 150 mM. An average N2 of 2 is assumed
for all binding processes.
I T N1 ∆HITC1 kb1 · 103 ∆Gb1 ∆Hb1 ∆Sb1
(mM) (◦C) (kJ/mol) (mol−1) (kJ/mol) (kJ/mol) (J/mol/K)
First binding site
Native HSA
20
25 0.68±0.01 −56.6±0.5 343±6 −31.59±0.06
−50±2 −61±730 0.48±0.01 −82.2±0.5 279±3 −31.60±0.05
37 0.57±0.01 −71±1 136±5 −30.49±0.09
150
25 0.59±0.01 −48±1 122±2 −29.04±0.05
−51±3 −75±1030 0.60±0.01 −52±2 83±4 −28.6±0.1
37 0.55±0.02 −59±2 55±2 −28.1±0.1
Urea modified HSA
20
25 0.91±0.01 -55.7±0.3 349±8 -31.64±0.06
−62±2 −100±830 0.89±0.01 −59.3±0.5 237±8 −31.20±0.08
37 0.89±0.01 −65.4±0.6 134±4 −30.44±0.07
150
25 0.87±0.01 −46.5±0.5 130±4 −29.19±0.08
−49±4 −68±1330 0.84±0.01 −48.3±0.8 103±5 −29.1±0.1
37 0.83±0.01 −55.6±2 59±3 −28.3±0.1
I T ∆HITC2 kb2 · 103 ∆Gb2 ∆Hb2 ∆Sb2
(mM) (◦C) (kJ/mol) (mol−1) (kJ/mol) (kJ/mol) (J/mol/K)
Second binding site
Native HSA
20
25 −82.3±0.8 4.2±0.08 −20.68±0.05
−10±3 35±1030 −42.0±0.6 4.1±0.2 −20.98±0.09
37 −34.2±0.8 3.5±0.2 −21.0±0.1
150
25 −68±54 0.63±0.09 −16.0±0.3
−35±27 −63±9030 −78±16 0.5±0.1 −15.6±0.6
37 −82±39 0.4±0.2 −15.4±1
Urea modified HSA
20
25 −60±1 3.1±0.1 −19.96±0.08
−12±4 28±1330 −56±2 3.0±0.1 −20.2±0.1
37 −56±2 2.6±0.1 −20.3±0.1
150
25 −60±9 0.9±0.1 −16.9±0.3
−4±19 42±6330 −61±10 1.0±0.1 −17.4±0.3
37 −81±18 0.6±0.2 −16±1
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6.2 Characterization of protein-toxin complexes in solution
The question addressed in the following Section is whether uptake of drugs influences the
structure of the protein or the protein-protein interaction. The interparticle interaction
is extracted by measuring the structure factor of high concentrated HSA-toxin solutions.
Crystallographic studies of HSA-IDS complexes revealed no significant conformational
changes associated with the binding. [84] However, these studies cannot be performed in
solution and consequently not under physiological conditions.
All neutron scattering experiments were performed at 37 ◦C and at pH 7.2. Two ionic
strengths, 10 mM and 150 mM, were adjusted using 10 mM MOPS as buffer solution and
NaCl as salt. A stock solution of 40 g/L HSA in 10 mM buffer was prepared and the
toxin concentrations were chosen to achieve full saturation of binding as determined by
ITC. For urea modified HSA solutions, samples were dialyzed after 18 h incubation and the
concentration was determined afterwards to be approximately 25 g/L. 3 These HSA-toxin
samples were subsequently diluted by buffer solution to 22 g/L and 19 g/L. An overview of
the experiments is given in Table 6.4.
Figure 6.14: Structure of na-
tive HSA, HSA complexed
with uremic toxins and urea
modified HSA at low salt
concentration. The concen-
tration of HSA is 40 g/L
in all samples except in
the urea modified sample,
the concentration is approx-
imately 25 g/L. Scattering
data are taken at 37 ◦C and
I = 10 mM.
Representative scattering intensities of samples with a HSA concentration of 40 g/L and
10 mM ionic strength are shown in Figure 6.14. The scattering intensities are similar at first
sight and small differences are only seen in the low q range, where the effect of structure
factor is observed as a decrease of intensity.
The fitting procedure of the data is explained on a representative example and demonstrated
in a plot in Figure 6.15. The analysis was carried out in three steps:
3Details of sample preparation are given in Section 8.1 of the Appendix.
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Table 6.4: Overview of neutron experiments of HSA complexation with three additives: PhAA,
IDS and urea at two ionic strengths 10 mM and 150 mM. All experiments were carried out at
37 ◦C with 10 mM MOPS as buffer solution.
Sample c(HSA)±0.1 Additive c(add.)±0.1 Molar ratio Ionic strength
name in g/L in g/L HSA:add. in mM
H30 30 - -
none 10H35 35 - -
H40 40 - -
HP30 30
PhAA
0.26
1:5 10HP35 35 0.33
HP40 40 0.35
HPI40† 12 1 1:41
150HPI200† 12 5 1:203
HPI400† 12 10 1:406
HS30 30
IDS
0.7 1:6
10HS35 35 0.7 1:5
HS40 40 0.8 1:5
HU19 18.9
Urea
1.8
1:50 10HU22 22.2 1.6
HU25 25.2 1.4
HI 40 none - -
150
HPI 40 PhAA 0.35 1:5
HSI 40 IDS 0.7 1:5
HUI 25.2 Urea 1.8 1:50
† Experiments were performed at the TOF instrument V16.
All other experiments were performed at the monochromatic instrument V4.
1. To obtain the particle scattering P (q) without the influence of the structure factor in
low q range, only the high q-range of the scattering curve was used, with q > 0.05 (as
indicated by the arrow in the top panel of Figure 6.15). The software Gnom was used
to fit the data and a curve is obtained which very well describes the intermediate and
high q-range of the scattering data (dashed black line). This fit performed by Gnom
includes a scaling factor, which accounts for the concentration and the contrast of
the scattering particles. The thus obtained and scaled P (q) is then extrapolated to
the lowest measured q values. I0 and Rg are the two parameters derived from the
Gnom fit.
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2. The total scattering intensity I(q) is proportional to the product of P (q) and the
structure factor S(q) 4 (see Equation (3.39)), [127] therefore S(q) is calculated by
dividing I(q) by P (q) (blue circles in the bottom panel of Figure 6.15). S(q) is most
prominent in the low q region and was fitted using the range as indicated in the plot
(0.015 < q < 0.13). A model describing the interaction of charged particles screened
by salt ions in solution, is the Hayter-Penfold Mean-Sphere approximation (HPMSA)
(see Section 3.3.2). [130] Here, the volume fraction φ, the temperature (T = 37 °C), the
ionic strength in the solution (I = 10 & 150 mM) and the dielectric constant H2O = 81
are known parameters and fixed in the fitting procedure. This leaves only two free fit
parameters: the effective charge valency |Z| and the diameter of the particles d. These
two parameters are not correlated, as demonstrated in Section 3.3.2.1 (see Figure 3.8),
and can thus be fitted simultaneously.
3. Finally, the total fit (blue line) is obtained by simply multiplying S(q) and P (q). No
additional fitting is performed in this step. However, the experimental data is well
described by the resulting fit as seen in Figure 6.15.
Figure 6.15: Demonstration of the details of the fitting procedures on the example of 30 g/L pure
HSA in solution (H30). Top panel: different parts of the scattering profile (red circles) is used to
fit the particle scattering (P (q)) and the structure factor (S(q)), respectively, as indicated by the
arrows in the plot. P (q) is obtained using Gnom [171] (dashed black line). The total fit (blue line)
is obtained by multiplication of the two single fits. Bottom panel: experimental structure factor
S(q) (blue circles) are fitted using the Hayter-Penfold Mean-Sphere approximation (HPMSA).
4Additional parameters contributing to scattering as given in Equation (3.39) are included in the
fit of P(q).
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For each type of system, three different concentrations were measured (see Table 6.4) and
fitted according to the procedure explained above. Representative series of measurements
for solutions of native HSA and HSA complexed with PhAA are shown in Figure 6.16a)
and b), respectively. While the top panel depicts P (q) (black line) and resulting total
fit (green line) to the scattering data (red circles), the bottom panel shows the structure
factor contribution towards scattering (blue circles) and corresponding fits (red lines). As
demonstrated in the case of HSA, the interaction between proteins in the solution are well
described by the HPMSA structure factor for charged macromolecules screened by salt ions
in the solution (see Section 3.3.2 for details). The effect of structure factor decreases with
decreasing concentration in the solution as expected. An overview of results obtained is
given in Table 6.5.
Figure 6.16: Series of dilution of (a) pure HSA solution and (b) HSA+PhAA complex and
corresponding fits. Top panels depict the fit for P (q) (black line) and the total fit (green
line). Bottom panels show experimental (blue circles) and fitted structure factor (red line) after
dividing the scattering profiles by P (q). For clarity, the two scattering intensities in the top
panels are shifted by a factor of 10 and 100, respectively, with respect to the scattering intensity
of 30 g/L. S(q) of the 40 g/L and 35 g/L in the bottom panels are shifted by a factor of 1.5 and
2.5, respectively.
A series of concentrations for native and pure HSA solution with corresponding fits and
the experimental structure factor is shown in Figure 6.16a). The results summarized in Ta-
ble 6.5 reveal that an effective charge valency |Z| of approximately 13± 1 was found for all
concentrations, which is very close to the net charge of HSA of 14 at pH 7.2. [149] The radius
of gyration was determined by Gnom and yields (26.4± 0.5) Å, which is the same value
found within the limits of error in the diluted condition of approximately (27± 0.5) Å as
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demonstrated in Section 5.2.2. The diameters obtained for the protein from the structure
factor fits are in average d ≈ 72± 2 Å and are comparable to crystallographic dimensions of
89 Å x 77 Å x 15 Å 5. In general, these results validate the fitting procedure described above.
The scattering results obtained for HSA-PhAA complex in Figure 6.16b) are in fact very
similar to measurements of pure HSA solutions. The charge valency |Z| is approximately
13 ± 1 and no significant difference to the charge of pure HSA is observed within the
range of error. With only two PhAA molecules adsorbed onto HSA as seen by ITC, their
influence on the interaction between the proteins is apparently not observable by SANS.
The diameters found for the HSA-PhAA complex are in average d = 69 ± 2 Å which is
almost equal to the values for pure HSA solutions of d ≈ 72 Å. For HSA-IDS complexes,
a small increase in charge is found compared to pure HSA, with |Z| = 15 ± 1 (|Z|(pure
HSA) = 14 ± 1). A possible explanation is that three IDS molecules adsorb to HSA as
revealed by ITC in the previous Section. [84] Furthermore, a similar value for the diameter d
as for pure HSA samples is found with an average of d ≈ 68±2 Å (see Table 6.5). Experimen-
tal data and corresponding fits of HSA-IDS complex are given in Figure 8.13 of the Appendix.
In general, no prominent effect of toxin adsorption on the size or effective charge of HSA
is observed by SANS. This is validated by comparing different structure factors of the
HSA-toxin complexes (40 g/L HSA) in Figure 8.14 of the Appendix. The typical structure
factor peak at q ∼ 0.04 Å−1 remains invariant with HSA-toxin complexation compared to
pure HSA data and thus the deduced value for the diameter d is constant in all samples.
Furthermore, the results of the S(q) fits for various concentrations give reliable values for
both the diameter and charge of the systems which are constant over concentration as clari-
fied in Figure 6.17. A small difference is observed for the urea modified HSA measurement,
where a shift of the maximum of the structure factor to lower q values is observed. Here,
concentrations are lower and a more detailed analysis is performed in the following.
Scattering data of a series of urea modified HSA solutions are depicted in Figure 6.18. The
concentrations measured here are lower and thus the fitting of the structure factor at lowest
concentrations is associated with higher uncertainties. For the lower HSA concentrations of
22.2 g/L and 18.9 g/L, very weak interparticle scattering is observed in the scattering data
and the fit for P (q) (black line) and the total fit (green line) almost overlap. Thus results of
the fitting of S(q) obtained for these measurements are associated with high uncertainties
and will not be considered in the interpretation. The HPMSA fit results indicate that in
contrast to the native HSA series, a significantly increased charge is found for the highest
concentration, where the best fit result is achieved. An effective charge of approximately
19± 1 is obtained here. The diameter d = 73± 1 Å is comparable to the results obtained
for native HSA.
5The crystal data with PDB-ID: 1AO6 was analyzed in terms of size and structure using the
software VMD.
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Figure 6.17: Overview of fit results for pure HSA and HSA-toxin solutions. The two parameters
derived from the S(q) fits (a) diameter d and (b) charge valency |Z| are constant over the
concentration range measured.
Figure 6.18: Series of dilution of HSA-Urea complex and corresponding fits. (a) Particle scattering
fit P (q) (black line) and the total fit (green line) are drawn on top of experimental data (red
circles). (b) Experimental (blue circles) and fitted structure factor (red line) after dividing the
scattering profiles by P (q). Scattering profiles are scaled with the same factors as in Figure 6.16.
The effect of ionic strength (I = 150 mM) on the interaction between HSA-toxin complexes
was investigated. Experiments were performed with a HSA concentration of 40 g/L for pure
HSA and HSA-toxin complexes. The concentration for the urea modified HSA sample was
25.2 g/L as in Figure 6.18. The impact of salt in solution is evident in Figure 6.19 when
comparing to Figure 6.14, as interactions between proteins are almost completely screened
with S(q) ≈ 1. In general, scattering intensities of all measured samples are very similar.
The results of the form factor fit are listed in Table 6.5, where a smaller Rg is observed in
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Table 6.5: Summery of results obtained by the combined P (q) and S(q) fit. While I0 and Rg
values are obtained by Gnom, the diameter d and charge valency |Z| are results of the HPMSA
fit.
Sample name c(HSA) I0 ± 0.01 MW ± 5 Rg ± 0.5 d± 2 |Z| ± 1
in g/L in cm−1 in kDa in Å in Å
I = 10 mM
pure HSA
40 2.13 50 26.5 71 14
35 1.93 52 26.4 72 13
30 1.58 49 26.4 72 14
HSA + PhAA
40 2.19 51 26.1 70 13
35 1.95 52 26.4 71 13
30 1.6 50 26.0 67 12
HSA + IDS
40 2.08 49 26.3 67 15
35 1.85 42 26.5 67 15
30 1.58 49 26.1 71 16
HSA-urea
25.2 1.26 47 26.3 73 19
22.2 1.11 47 26.5 (86)∗ (13)∗
18.9 0.95 47 26.4 (99)∗ (9)∗
I = 150 mM†
pure HSA
40
1.89 44 25.2 - -
HSA + PhAA 2.12 50 25.8 - -
HSA + IDS 2.02 47 25.8 - -
HSA-urea 25.2 1.03 38 25.3 - -
† A diameter d and a charge valency |Z| cannot be determined, as structure factor
is considerably screened by the high concentration of salt in the solution.
∗ Due to the high uncertainties of these values, they are not taken into consideration
in the interpretation of the data.
comparison to very stable values of Rg at 10 mM salt.
An impact of urea modification or toxin uptake on the structure of HSA is not reflected
in the results of the fits. This finding is confirmed when looking at the Kratky plot
in Figure 6.20. No significant difference between pure HSA samples, HSA complexed with
toxins or urea modified HSA samples are observed. This result allows the interpretation of
ITC measurements in the previous Sections as the heat signals consequently originate only
from the binding process.
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Figure 6.19: Scattering data
of 40 g/L HSA with differ-
ent additives at I = 150 mM.
Native HSA (red circles)
are compared to HSA sam-
ple with different additives:
PhAA (blue triangles), IDS
(green crosses), and urea
modified samples (yellow tri-
angles). A pure form fac-
tor fit is shown as black line.
The concentration of urea
modified HSA is 25.2 g/L.
Figure 6.20: Kratky plot of
the scattering data shown
in Figure 6.19. The scatter-
ing profiles were normalized
to I0 prior to enable a com-
parison between the differ-
ent concentrations.
The interaction between proteins in solution can be well characterized by SANS by analyzing
the structure factor of the scattering intensities. While the structure of HSA remains
insensitive to toxin adsorption or urea modification, small differences in the interaction
potential between the urea modified HSA sample to all other measured samples were
detected by SANS. In the present study this effect is seen in a change of the parameter |Z|
from 14 to 19 upon urea modification. It is known from literature that urea will induce
carbamylation of certain residues [39, 201] and thus a possible influence on the interaction
between the proteins cannot be excluded. Furthermore, the results in the present Section
indicate that such an influence is not distinctly observed by the uptake of the other two
toxins.
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7 Summary
The studies presented in this thesis are aimed at understanding binding mechanisms
and underlying driving forces for the interaction of ligands to the most abundant blood
protein human serum albumin (HSA). The combination of a calorimetric with a scattering
technique allows comprehensive insight into the binding process combining thermodynamic
with structural information. Two different types of ligands were presented, both of them
representing different important binding mechanisms and driving forces:
• The first model ligand is a short and weak acidic polyelectrolyte (PE) with 25
repeating monomers, each containing a carboxyl group, to explore charge-charge
interactions. At physiological pH both interacting partners are negatively charged
and form a soluble PE-protein complex as presented in the first part of the present
thesis. Systematic ITC experiments exploring both effects of changing temperature
and salinity gave clear evidence of an one-to-one binding of the polyelectrolyte PAA
to HSA. A significant increase of binding affinity Kb with increasing temperature
was found. On the dependency on salinity, a decrease of ∆Gb with increasing
ionic strength was observed and the interaction vanishes for as high salinity as
approximately 600 mM. The analysis of the binding affinity and its dependency on
salt concentration reveal that three ions are released upon binding. This finding
together with the measured endothermic enthalpy of reaction and a favorable change
of entropy gave clear evidence that the strong binding is driven by the counterion
release effect. Theoretical computational simulations support these results, counting
in average 2.5 ions released upon binding which contribute significantly to the overall
binding free energies. Finally, the total binding free energies deduced by simulations
∆Gsimb are in good agreement with experimental results.
• To investigate possible structural modifications of native HSA after complexation
with PAA, neutron scattering experiments were conducted first on pure HSA solutions
under different ionic strength conditions. These reference experiments revealed minor
changes of the tertiary structure when increasing salt concentration in the solution.
Furthermore, the average scattering length ρ¯ and radius of gyration at infinity contrast
Rg,∞ were determined from contrast variation experiments. Rg,∞ was found to be
slightly larger than the values at maximum contrast. Additionally, studies comparing
HSA isolated from healthy individuals and patients suffering from CKD give evidence
that pathologically modified HSA possibly lead to an altered protein surface charge
and thus induce aggregation. With the structure of native HSA clarified, the effect
of PAA adsorption on the protein was studied under high and low ionic strength
conditions. The obtained results reveal a preserved protein structure upon adsorption
of PAA.
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• The second part of the thesis is devoted to the adsorption of uremic toxins to HSA.
Unlike the polyeletrolyte, the two toxins studied bear only one charged moiety and a
hydrophobic benzene group. The thermodynamic analysis of the binding reveals that
there are two binding sites for both the the toxins with different binding affinities
and stoichiometry. For phenylacetic acid (PhAA) the ionic strength dependence
was analyzed using a Debye-Hückel approach. [182] The analysis demonstrated that
binding is driven by a favorable hydrophobic interaction that yield constant binding
free energies ∆Gb over the investigated range of temperature and ionic strength.
This in turn indicates that enthalpy-entropy compensation (EEC) occurs, where
the binding of a ligand in a cavity leads to an unfavorable change of entropy but
is compensated by a favorable enthalpy contribution due to the release of water
moleculs. [202, 203] Finally, in vitro modifications of HSA by urea do not alter the
interaction between protein and toxin and has only minor influence on the binding
affinities.
• Neutron scattering results again confirm a stable protein structure upon adsorption.
Investigation of high concentrated solutions of HSA-ligand complexes reveal no sig-
nificant change in interaction between the loaded proteins upon adsorption of the
toxins. The urea modified proteins however, exhibit an increase of effective charge
from −14 e to −19 e.
In conclusion, the present thesis has contributed to an in-depth understanding of the
interaction between ligands/polyelectrolytes with proteins and identified the different driving
contributions that leads to binding. These insights help to elucidate the nephrological
relevant problem of toxin adsorption to HSA and thus cleared the path to improve renal
dialysis techniques. In particular, combining computer simulations with calorimetry provide
an accurate picture of binding mechanisms and driving forces. These insights can form the
basis for more general predictions to address biochemical challenges such as drug targeting
and delivering problems.
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8.1 Sample preparation and protein characterization
Materials. All materials were purchased Sigma-Aldrich® (Schnelldorf, Germany). The
buffer morpholin-N-oxide (MOPS) and the uremic toxins phenylacetic acid (PhAA) and
indoxyl sulfate potassium salt (IDS) were used as received. The polyelectrolyte polyacrylic
acid (PAA) with MW = 1800 g/mol was dialysed for several weeks to match pH without
changing ionic strength in the system. Human serum albumin (HSA) (lyophilized powder,
fatty acid free, globulin free, 99%) with molecular weights of approximately MW = 66,200
- 66,400 g/mol according to Sigma-Aldrich, was also dialyzed prior to its use and the
concentration afterwards determined by UV-vis spectroscopy as shown in Figure 8.2. The
density of the protein was determined to 1.3 g/L using the density meter DMA 602 by
Anton Paar (Graz, Austria).
In vitro urea modification of albumin. In vitro modification of HSA was carried
out in a 10 mM MOPS buffer solution with 15 g/l HSA and 10 mM urea at 37◦C and pH
7.2 for 18 h. After incubation, the mixture was dialyzed against buffer using centrifugation
dialysis several times. Concentrations were then determined by UV-vis.
Figure 8.1: Density of HSA
was determined by measur-
ing a series of HSA solu-
tions at 37°C and pH 7.2
using a density meter.
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Figure 8.2: UV-vis measurement of a series of HSA concentrations. (a) A representative HSA
(1.7 g/L) absorption spectra with an characteristic peak at 278 nm. (b) The absorption value at
278 nm was measured for different HSA concentrations and fitted with a line. These reference
measurements were the basis to determine HSA concentrations.
8.2 Small-angle neutron scattering
To elucidate the limits in performance of the programs, the following theoretical experiments
were conducted and depicted in Figure 8.3:
Based on the known crystallographic data of HSA1, Cryson was used to calculate theoretical
scattering intensities (yellow circles) for q values in the range of 0 < q < 1 Å−1 (see Fig-
ure 8.3). Different q-ranges of these intensities were then used as input for Gnom to evaluate
the effect of different boundary conditions for Dmax. The impact of two different input
values for q on the fitting results of Gnom, specifically a short 0 < q < 0.2 Å−1 (blue lines)
and a long 0 < q < 1 Å−1 (green lines) q-range is demonstrated in Figure 8.3. Furthermore,
these two ranges were analyzed in combination with the choice of two typical values for
Dmax = 70 Å (solid line) and 85 Å (broken line). The boundary condition P (r = 0) = 0
was set for all calculations.
The most significant deviation of the Gnom fit from the calculated intensities is observed in
the high q-range beyond approximately 0.3 Å, where the full q-range is used as input to
Gnom. This range is magnified in the inset of Figure 8.3a) and it is here, where the effect
of different Dmax comes into play. While the choice of Dmax (with the border condition
p(Dmax) = 0) does not affect the quality of the fit for short q-ranges, its impact on the
high q-range clearly evolves (green dashed and solid lines). For HSA as seen by crystal-
lography, Dmax=85 Å is a good approximation, which is also reflected in the P (r) profiles
(Figure 8.3b)). Here, the dashed lines show an overall more smooth profile than the solid
lines, where Dmax = 70 Å is an apparently too small estimate.
As mentioned before, Gnom uses the Equation (5.5) to calculate I(0) and Rg. The according
values for the four fits are listed in Table 8.1 below. Apparently, both radii and forward
scattering intensities are robust results, not very sensitive to the available q-range and Dmax.
1PDB-ID: 1AO6 taken from [169]
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Figure 8.3: Effect of different input data on the result of Gnom data evaluation. Different fits for
a calculated scattering intensity are compared in a standard log-log plot in (a), where the inset
shows a magnified view of the high q range. PDDF profiles calculated by Gnom for the different
profiles are displayed in (b).
This finding is not surprising, as the region contributing to the analysis q < 0.041 < Dmax/pi
is an order of magnitude below the short q-range data.
Table 8.1: Effect of q-range input and the choice of Dmax on the evaluation by Gnom. Fit results
I(0) and Rg are summarized in dependence on different q-ranges and Dmax.
q range in Å−1 Dmax in Å Rg in Å I(0) in cm−1
0 - 0.2
70 25.51 0.9998
85 25.53 1
0 - 1
70 25.5 0.9998
85 25.52 1
The difference in scattering at each instrument is reviewed in the following. HSA solution
prepared in MOPS buffer and ionic strength 150 mM were measured at three instruments:
V16, D11 and KSW II. As elucidated in Section 4.2.1, two of these instruments use monochro-
matic sources, while one (V16 @ HZB) use a spectrum of neutron wavelengths. The subtle
difference in scattering profiles measured using different techniques is made visible in the
Kratky plot in Figure 8.4. Intensities at the monochromatic instruments D11 and KSW II
coincide very well, while deviation is seen in the HSA profile measured at V16. This can
be explained by the effect of wavelength smearing that is described by ∆λ/λ. However, a
quantification of this value is experimentally very difficult. The effect is reflected in the
second shoulder, which is less pronounced and more “smeared” in the data measured at
V16, compared to the other two and the theoretical profile. A further observation correlated
to the different smearing of the instruments is made for the fitted Rg values. While Rg is
very similar for the two monochromatic instruments, the value obtained from the profile of
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the TOF instrument is slightly smaller. However, the difference is subtle and at the edge of
resolution of the technique in general.
Figure 8.4: Native HSA in 150 mM
salt and buffer solution at 37◦C. A
Kratky plot reveals subtle differences
in scattering data obtained at differ-
ent instruments.
The forward scattering intensities I0 obtained at different concentration and instruments
are evaluated and plotted against concentration in Figure 8.5. The dashed line is a fit with
I(q = 0) = 0 and confirm a linear relationship as expected from Equation (3.52). However,
the error bars are relatively large (see Table 5.3) and deviation at higher concentration (at
a volume fraction of about 1%) may be explained by the presence of contributing structure
factor that will influence the determination of I0.
Figure 8.5: Fitted primary intensity
I0 of HSA in different buffer solution.
Measurements were performed at dif-
ferent facilities.
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Figure 8.6: Guinier fits (lines) of scattering data shown in Figure 5.14 for the low q range with
(a) I = 25 mM and (b) I = 150 mM. The derived values for I(0) and Rg are listed in Table 5.4.
Figure 8.7: Kratky plot of HSA-PAA complexes in comparison to native HSA. The molar ratio
of the complexes are 1:8 HSA to PAA. While MOPS was used as buffer, ionic strength was
adjusted with two types of salt, which are monovalent NaCl (red) and divalent MgCl2+CaCl2
(blue).
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8.3 Polyelectrolyte binding to HSA
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Figure 8.8: Raw ITC data and integrated heats are shown for a) I = 70 mM and b) 100 mM at T
= 37◦C.
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Figure 8.9: Number of positive condensed ions (PCI) and negative condensed ions (NCI) versus
distance for ionic strength I = 20 mM (left) and 50 mM at a temperature of 25°C.
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Figure 8.10: Density profiles of
positive salt ions around the
PAA monomers at 20 and
50 mM salt concentration. In
the binding layer of condensed
ions r < 0.5 nm the ion concen-
tration is about 1.5 M.
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Figure 8.11: Adsorption of IDS to native and modified HSA. Temperature series measured at I =
20 mM and according fits using the TSIS model are shown for (a) native HSA (b) urea modified
HSA.
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Figure 8.12: Ionic strength dependence of the second binding process and low affinity site.
Adsorption of of PhAA (brown) and IDS (green) to native (full symbols) and modified HSA
(empty symbols) are shown. Spheres and rectangles represent 25◦C and 37◦C.
Figure 8.13: Scattering in-
tensities of the HSA-IDS
complex at different con-
centrations. Top panel de-
pict measured experimen-
tal data (red points) with
corresponding P (q) (black
line) and total fits (green
line) plotted on top. Bot-
tom panel shows experimen-
tal (blue circles) and fitted
structure factor (red line).
Data are scaled for better
comparison.
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Figure 8.14: Structure factor fits for all samples measured at highest concentration 40 g/L and
25.2 g/L for urea modified HSA. The data are shifted relative to native HSA data by constant
offsets of 0.5, 1 and 1.5 respectively.
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Table 8.2: Table comparing different methods to study binding between proteins P and ligands L.
ITC FS ED UF UC SPR CE
Sample none labelling none none immob. nonemanipulation
Multiple yes yes yes yes yes no yesbinding sites
Kinetics none yes none none none yes yes
Sample P:1-1.4 mL 0.5 mL 0.5-1 mL 0.5-1 mL 0.5-1 mL 30-500 µL nLvolume L:250-300 µL 0.5 mL
Sample conc. P: 5-100 µM P:mM-µM µM µM-mM mM L:µM µML: mM P:50-100µg
Affinity range 103-109 103-1010 102-1012 102-108 103-108 106-1011 102-107
kb in mol−1
Information Kb, n, ∆H Kb, n Kb, binding site Kb, n Kb, n Kb, n,kon/koff Kb, n∆Gb, ∆Sb, ∆Cp
Advantages • full thermodyn. • kinetic data • simple • simple • simple • kinetic data • small sample
information • low sample conc. • inexpensive • fast • no membrane • small sample amount
• no sample • can measure involved amount • rapid & simple
manipulation high affinities
• precision, robust • reproducibility • high efficiency
Drawbacks • exp. setup depends • labelling • volume shifts • volume shift • sedimentation • immobilization • protein adsorp.
on interest • uncertain n • NSB∗ • NSB∗ • back diffusion • stoichometry not on walls
• complicated analysis • indirect • Donnan effect • disturbed • viscosity directly measured • low sensitivity
• all processes method • NPC∗ equilibrium • low throughput of UV signal
contribute • NPC∗ • NPC∗
ITC: Isothermal titration calorimetry; FS: Fluorescence spectroscopy; ED: Equilibrium dialysis; UF: Ultrafiltration; UC: Ultracentrifugation; SPR: Surface
plasmon resonance-based assays; CE: Capillary electrophoresis
∗ NSB: nonspecific binding, NPC: no physiological condition
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